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Abstract
The three-event stack cotton GHB614 9 T304-40 9 GHB119 was produced by conventional crossing to
combine three single events, GHB614, T304-40 and GHB119. The genetically modiﬁed organisms (GMO)
Panel previously assessed the three single cotton events and did not identify safety concerns. No new
data on the single cotton events that could lead to modiﬁcation of the original conclusions on their safety
were identiﬁed. Based on the molecular, agronomic, phenotypic and compositional characteristics, the
combination of the single cotton events and of the newly expressed proteins in the three-event stack
cotton did not give rise to food and feed safety concern. The GMO Panel considers that the three-event
stack cotton GHB614 9 T304-40 9 GHB119 has the same nutritional impact as its comparator and the
non-GM reference varieties tested. The GMO Panel concludes that the three-event stack cotton
GHB614 9 T304-40 9 GHB119, as described in this application, is nutritionally equivalent to and as safe
as its comparator and the non-GM reference varieties tested, and no post-market monitoring of food/feed
is considered necessary. In the case of accidental release of viable GHB614 9 T304-40 9 GHB119
cottonseeds into the environment, this three-event stack would not raise environmental safety concerns.
The post-market environmental monitoring plan and reporting intervals are in line with the intended uses of
cotton GHB614 9 T304-40 9 GHB119 seeds. The GMO Panel concludes that cotton GHB614 9 T304-40 9
GHB119, as described in this application, is as safe as its comparator and the tested non-GM reference
varieties with respect to potential effects on human and animal health and the environment.
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Summary
Following the submission of an application (EFSA-GMO-NL-2014-122) under Regulation (EC) No 1829/
20031 from Bayer CropScience N.V., the Panel on Genetically Modiﬁed Organisms of the European Food
Safety Authority (GMO Panel) was asked to deliver a scientiﬁc opinion on the safety of insect-resistant and
herbicide-tolerant genetically modiﬁed (GM) cotton GHB614 9 T304-40 9 GHB119. The scope of
application EFSA-GMO-NL-2014-122 is for import, processing and food and feed uses but excludes
cultivation in the European Union (EU) and covers the three-event stack cotton GHB614 9 T304-40
9 GHB119 in cotton species Gossypium hirsutum and Gossypium barbadense.
In delivering its scientiﬁc opinion, the GMO Panel considered the data available on the single events,
the information presented in application EFSA-GMO-NL-2014-122, additional information provided by the
applicant, the scientiﬁc comments submitted by the Member States and relevant scientiﬁc publications.
The three-event stack cotton GHB614 9 T304-40 9 GHB119 was produced by conventional crossing to
combine three single events: GHB614 (expressing the modiﬁed 5-enolpyruvyl-shikimate-3-phosphate
synthase (2mEPSPS) protein)), T304-40 (expressing Cry1Ab and phosphinothricin acetyltransferase
(PAT)) proteins) and GHB119 (expressing Cry2Ae and PAT proteins) to confer resistance to certain
lepidopteran pests and tolerance to glyphosate- and glufosinate ammonium-based herbicides.
The GMO Panel evaluated cotton GHB614 9 T304-40 9 GHB119 with reference to the scope and
appropriate principles described in Regulation (EU) 503/20132 and EFSA guidelines for the risk
assessment of GM plants and derived food and feed, the environmental risk assessment of GM plants and
the post-market environmental monitoring (PMEM) of GM plants. These establish the principle that where
all single events have been assessed, the risk assessment of stacked events should focus mainly on
issues related to (a) stability of the inserts, (b) expression of the introduced genes and their products and
(c) potential synergistic or antagonistic effects resulting from the combination of the events.
For application EFSA-GMO-NL-2014-122, the previous assessment of the three single cotton events
(GHB614, T304-40 and GHB119) provided the basis to evaluate the three-event stack cotton. Cotton
GHB614, T304-40 and GHB119 were previously assessed by the GMO Panel and no safety concerns
were identiﬁed. No safety issue was identiﬁed by updated bioinformatics analyses nor reported by the
applicant for any of the three single cotton events since the publication of the respective scientiﬁc
opinions. In line with Regulation (EU) 503/2013, the GMO Panel assessed the three 90-day toxicity
studies on the whole food/feed from the single events GHB614, T304-40 and GHB119 and concludes
that no adverse effects were noted in these studies. Consequently, the GMO Panel considers that its
previous conclusions on the safety of the single cotton events remain valid.
Based on the relevant publications identiﬁed through the literature searches, the GMO Panel did not
identify any safety issues pertaining to the intended uses of cotton GHB614 9 T304-40 9 GHB119. In
the context of PMEM, the applicant should improve the literature searches according to the GMO
Panel recommendations.
The evaluation addressed the following components of the risk assessment: the molecular
characterisation of the inserted DNA and analysis of the expression of the corresponding proteins; the
comparative analyses of compositional, agronomic and phenotypic characteristics; the safety of the
newly expressed proteins and the whole food/feed with respect to potential toxicity, allergenicity and
nutritional characteristics; and the environmental risk assessment and the PMEM.
The molecular data establish that the events stacked in cotton GHB614 9 T304-40 9 GHB119 have
retained their integrity. Protein expression analysis shows that the levels of the newly expressed
proteins are similar in the three-event stack cotton and in the single events. PAT shows the expected
higher level in the stack resulting from the combination of the single cotton events T304-40 and
GHB119. Therefore, there is no indication of an interaction that may affect the integrity of the events
and the levels of the newly expressed proteins in this stack.
Given the magnitude of the differences observed in the comparative assessment, the nature of the
endpoints and the outcome of the equivalence test, the GMO Panel considers that none of the agronomic
and phenotypic differences between cotton GHB614 9 T304-40 9 GHB119 and the comparator needs
further assessment for its potential environmental impact except the percentage of lint. This difference
was further assessed and found not to affect the ability of cotton GHB614 9 T304-40 9 GHB119 to
1 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
2 Commission Implementing Regulation (EU) No 503/2013 of 3 April 2013 on applications for authorisation of genetically
modiﬁed food and feed in accordance with Regulation (EC) No 1829/2003 of the European Parliament and of the Council and
amending Commission Regulations (EC) No 641/2004 and (EC) No 1981/2006. OJ L157, 8.6.2013, p. 1–48.
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survive until subsequent seasons or to establish occasional feral plants under European environmental
conditions. The GMO Panel does not identify the need for further food/feed safety assessment on the
composition characteristics except for total fat, dihydrosterculic acid and a-linolenic acid. These
differences were assessed and do not raise concerns with regard either food and feed safety or
nutritional relevance.
The proteins 2mEPSPS, PAT, Cry1Ab and Cry2Ae newly expressed in the three-event stack cotton
do not raise concerns for human and animal health and no interactions between these proteins
relevant for food and feed safety were identiﬁed. Similarly, the GMO Panel does not identify indications
regarding the overall allergenicity of the three-event stack cotton. The nutritional impact of cotton
GHB614 9 T304-40 9 GHB119-derived food and feed is expected to be the same as those derived
from the comparator and non-GM reference varieties.
The GMO Panel concludes that cotton GHB614 9 T304-40 9 GHB119, as described in this
application, is nutritionally equivalent to and as safe as the comparator and the non-GM reference
varieties tested, and no post-market monitoring of food/feed is considered necessary.
Considering the combined events and their potential interactions, the outcome of the comparative
analysis, and the routes and levels of exposure, the GMO Panel concludes that cotton
GHB614 9 T304-40 9 GHB119 would not raise safety concerns in the case of accidental release of
viable GM cottonseeds into the environment. The PMEM plan and reporting intervals are in line with
the intended uses of cotton GHB614 9 T304-40 9 GHB119.
The GMO Panel concludes that cotton GHB614 9 T304-40 9 GHB119, as described in this
application, is as safe as its comparator and the tested non-GM reference varieties with respect to
potential effects on human and animal health and the environment.
Assessment of GM cotton GHB614 3 T304-40 3 GHB119
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1. Introduction
The scope deﬁned by the applicant at the time of submission is for import, processing and food and
feed uses but excludes cultivation in the European Union (EU) and covers the three-event stack cotton
GHB614 9 T304-40 9 GHB119 in cotton species Gossypium hirsutum and Gossypium barbadense.
1.1. Background
On 8 October 2014, the European Food Safety Authority (EFSA) received from the Competent
Authority of the Netherlands application EFSA-GMO-NL-2014-122 for placing on the market of
genetically modiﬁed (GM) cotton GHB614 9 T304-40 9 GHB119, submitted by Bayer CropScience N.V.
within the framework of Regulation (EC) No 1829/2003 on GM food and feed.
After receiving application EFSA-GMO-NL-2014-122, and in accordance with Articles 5(2)(b) and 17
(2)(b) of the Regulation (EC) No 1829/2003, EFSA informed the Member States and the European
Commission, and made the summary of the application publicly available on the EFSA website.3 EFSA
initiated a formal review of the application to check compliance with the requirements laid down in
Articles 5(3) and 17(3) of the Regulation (EC) No 1829/2003 and Regulation (EU) No 503/2013. On 23
March 2015 and on 9 April 2015, EFSA received additional information requested under completeness
check on 4 December 2014. On 30 April 2015, EFSA declared the application as valid in accordance
with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003.
EFSA made the valid application available to Member States and the European Commission and
consulted nominated risk assessment bodies of Member States, including national Competent Authorities
within the meaning of Directive 2001/18/EC4 following the requirements of Articles 6(4) and 18(4) of
Regulation (EC) No 1829/2003, to request their scientiﬁc opinion. Member States had 3 months after the
date of receipt of the valid application (until 21 February 2017) to make their opinion known.
The genetically modiﬁed organisms (GMO) Panel requested additional information from the
applicant on 27 September 2016, 16 December 2016, 23 February 2017, 12 April 2017, 11 May 2017,
1 August 2017, 1 September 2017, 7 December 2017, 15 February 2018 and 28 March 2018. The
applicant provided information on 13 December 2016, 14 February 2017, 27 March 2017, 30 March
2017, 28 July 2017, 15 September 2017, 2 February 2018, 20 February 2018 and 15 May 2018. The
applicant provided spontaneous information on 13 December 2016.
In the frame of the contracts OC/EFSA/GMO/2013/01 and OC/EFSA/GMO/2014/01, contractors
performed preparatory work and delivered reports on the methods applied by the applicant in
performing bioinformatics, toxicological and statistical analyses, respectively.
In giving its scientiﬁc opinion on cotton GHB614 9 T304-40 9 GHB119 to the European Commission,
Member States and the applicant, and in accordance with Articles 6(1) and 18(1) of Regulation (EC)
No 1829/2003, EFSA has endeavoured to respect a time limit of 6 months from the acknowledgement of
the valid application. As additional information was requested by the GMO Panel, the time limit of
6 months was extended accordingly, in line with Articles 6(1), 6(2), 18(1) and 18(2) of Regulation (EC)
No 1829/2003.
According to Regulation (EC) No 1829/2003, this Scientiﬁc Opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
1.2. Terms of Reference as provided by the requestor
The GMO Panel was requested to carry out a scientiﬁc assessment of cotton GHB614 9 T304-
40 9 GHB119 (G. hirsutum and G. barbadense) for food and feed uses, import and processing in
accordance with Articles 6(6) and 18(6) of Regulation (EC) No 1829/2003.
Where applicable, any conditions or restrictions which should be imposed on the placing on the
market and/or speciﬁc conditions or restrictions for use and handling, including post-market monitoring
requirements based on the outcome of the risk assessment and, in the case of GMOs or food/feed
containing or consisting of GMOs, conditions for the protection of particular ecosystems/environments
and/or geographical areas should be indicated in accordance with Articles 6(5)(e) and 18(5)(e) of
Regulation (EC) No 1829/2003.
3 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2014-00721
4 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the
environment of genetically modiﬁed organisms and repealing Council Directive 90/220/EEC. OJ L 106, 12.3.2001, p. 1–38.
Assessment of GM cotton GHB614 3 T304-40 3 GHB119
www.efsa.europa.eu/efsajournal 6 EFSA Journal 2018;16(7):5349
UN
DE
R 
RE
VI
EW
The GMO Panel was not requested to give an opinion on the information required under Annex II
to the Cartagena Protocol. Furthermore, the GMO Panel did not consider proposals for labelling and
methods of detection (including sampling and the identiﬁcation of the speciﬁc transformation event in
the food/feed and/or food/feed produced from it), which are matters related to risk management.
2. Data and methodologies
2.1. Data
In delivering its scientiﬁc opinion, the GMO Panel took into account application EFSA-GMO-NL-2014-
122, additional information provided by the applicant, scientiﬁc comments submitted by the Member
States and relevant scientiﬁc publications.
2.2. Methodologies
The GMO Panel carried out a scientiﬁc risk assessment of cotton GHB614 9 T304-40 9 GHB119 for
food and feed uses, import and processing in accordance with Articles 6(6) and 18(6) of Regulation
(EC) No 1829/2003. The GMO Panel took into account Regulation (EU) No 503/2013 and the
appropriate principles described in its guidelines for the risk assessment of GM plants and derived food
and feed (EFSA GMO Panel, 2011a), the conducting of repeated-dose 90-day oral toxicity study in
rodents on whole food/feed (EFSA Scientiﬁc Committee, 2011), the environmental risk assessment
(ERA) of GM plants (EFSA GMO Panel, 2010), and the post-market environmental monitoring (PMEM)
of GM plants (EFSA GMO Panel, 2011b). The GMO Panel took into account the criteria included in the
‘Explanatory statement for the applicability of the Guidance of the EFSA Scientiﬁc Committee on
conducting repeated-dose 90-day oral toxicity study in rodents on whole food/feed for GMO risk
assessment’ (EFSA, 2014), to perform the assessment of the 90-day feeding studies provided.
According to Regulation (EU) 503/2013 and as described in EFSA guidance ’For GM plants
containing a combination of transformation events (stacked events) the primary concern for risk
assessment is to establish that the combination of events is stable and that no interactions between
the stacked events, that may raise safety concerns compared to the single events, occur. The risk
assessment of GM plants containing stacked events focuses on issues related to: (a) stability of the
inserts, (b) expression of the introduced genes and their products and (c) potential synergistic or
antagonistic effects resulting from the combination of the events’ (EFSA GMO Panel, 2011a).
The GMO Panel also assessed the applicant’s systematic literature searches in accordance with the
guidelines on literature searching given in EFSA (2010, 2017). The comments raised by the Member
States are addressed in Annex G of EFSA’s overall opinion and were taken into consideration during
the scientiﬁc risk assessment.
3. Assessment
3.1. Introduction
Cotton GHB614 9 T304-40 9 GHB119 was developed by conventional crossing to combine three
single events: GHB614 (expressing the modiﬁed 5-enolpyruvyl-shikimate-3-phosphate synthase
(2mEPSPS) protein)), T304-40 (expressing Cry1Ab and phosphinothricin acetyltransferase (PAT))
protein) and GHB119 (expressing Cry2Ae and PAT proteins) to confer resistance to certain lepidopteran
pests and tolerance to glyphosate- and glufosinate ammonium-based herbicides.
All three single events were assessed previously (see Table 1) and no concerns for human and
animal health or environmental safety were identiﬁed.
Assessment of GM cotton GHB614 3 T304-40 3 GHB119
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3.2. Updated information on single events5
Since the publication of the scientiﬁc opinions on the single cotton events by the GMO Panel (see
Table 1), no safety issue concerning the three single events has been reported by the applicant.
Updated bioinformatic analyses for cotton events GHB614, T304-40 and GHB119 conﬁrms that no
known endogenous genes were disrupted by any of the inserts.
Updated bioinformatic analyses of the amino acid sequence of the newly expressed 2mEPSPS, PAT,
Cry1Ab and Cry2Ae proteins conﬁrm previous results indicating no signiﬁcant similarities to toxins and
allergens. Updated bioinformatic analyses of the newly created Open Reading Frames (ORFs) within
the inserts or spanning the junctions between the insert and the ﬂanking regions for events GHB614,
T304-40 and GHB119 conﬁrms that the production of a new peptide showing signiﬁcant similarity to
toxins or allergens is highly unlikely.
In order to assess the possibility for horizontal gene transfer (HGT) by homologous recombination
(HR), the applicant performed a sequence identity analysis for events GHB614, T304-40 and GHB119
to microbial DNA. The likelihood and potential consequences of plant-to-bacteria gene transfer are
described in Section 3.7.2.
Based on the above information, the GMO Panel considers that its previous conclusions on the
safety of the single cotton events remain valid.
3.3. Systematic literature review6
The GMO Panel assessed the applicant’s literature searches on cotton GHB614 9 T304-
40 9 GHB119, which include a scoping review, according to the guidelines given in EFSA (2010).
A systematic literature review as referred to in Regulation (EU) No 503/2013 has not been provided
in support to the risk assessment of the application EFSA-GMO-NL-2014-122. Based on the outcome of
the scoping review, the GMO Panel agrees that there is limited value of undertaking a systematic
review for cotton GHB614 9 T304-40 9 GHB119 at present.
Although the overall quality of the performed literature searches is acceptable, the GMO
Panel considers that future searches on cotton GHB614 9 T304-40 9 GHB119 should be improved.
The GMO Panel therefore recommends the applicant to:
 provide the search strategies that were actually run (the search history) – line by line with
the number of publications identiﬁed per line;
 ensure that enough search term variation is used (covering possible synonyms, related terms,
acronyms, spelling variants, old and new terminology, brand and generic names, lay and
scientiﬁc terminology, common typos, translation issues);
 use truncation consistently;
 include controlled vocabulary (subject indexing) in the searches when available, and where
subject headings are available use both free-text terms and controlled vocabulary in the
searches;
 assess the relevance and risk assessment implications of publications retrieved via searches
beyond electronic bibliographic databases.
None of the relevant publications identiﬁed through the literature searches report information
pointing to safety issues associated with the scope of application EFSA-GMO-NL-2014-122.
Table 1: Single cotton events already assessed by the GMO Panel
Event Application EFSA Scientiﬁc Opinion
GHB614 EFSA-GMO-NL-2008-51 EFSA (2009)
T304-40 EFSA-GMO-NL-2010-97 EFSA GMO Panel (2013)
GHB119 EFSA-GMO-UK-2010-96 EFSA GMO Panel (2016)
5 Dossier: Part II – Section 1.2.2.2; additional information: 13/12/2016 and 2/2/2018.
6 Dossier: Part II – Section 7, including relevant Appendices; additional information: 28/7/2017 and 15/9/2017.
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3.4. Risk assessment of the three-event stack cotton GHB614 3
T304-40 3 GHB119
3.4.1. Molecular characterisation
In line with the requirements laid down by Regulation (EU) 503/2013, the possible impact of the
combination of the events on the integrity of the events, the expression levels of the newly expressed
proteins or the biological functions conferred by the individual inserts are considered below.
3.4.1.1. Genetic elements and biological functions of the inserts7
Cotton events GHB614, T304-40 and GHB119 were combined by conventional crossing to produce
the three-event stack cotton GHB614 9 T304-40 9 GHB119. The structure of the inserts introduced
into the three-event stack cotton are described in detail in the respective EFSA scientiﬁc opinions
(Table 1) and no new genetic modiﬁcations were involved. Genetic elements in the expression
cassettes of the single events are summarised in Table 2.
Intended effects of the inserts in cotton GHB614 9 T304-40 9 GHB119 are summarised in Table 3.
Based on the known biological function (Table 3) of the newly expressed proteins, the only
foreseen interactions at the biological level are between the two Cry proteins in susceptible insects.
Table 2: Genetic elements in the expression cassettes of the events stacked in cotton
GHB614 9 T304-40 9 GHB119
Event Promoter 5’ UTR
Transit
peptide
Coding region Terminator
GHB614 Ph4a748At (histone
H4)
(Arabidopsis thaliana)
First intron of gene
II of histone H3.III
variant (A. thaliana)
Optimized tp
(Zea mays and
Helianthus
annuus)
2mepsps (Zea mays) 3’ histone H4
(A. thaliana)
T304-40 Ps7s7 (Subterranean
clover stunt virus
genome segment 7)
35S (Cauliﬂower
mosaic virus P35S3)
Tapetum-speciﬁc E1
(5’ e1 from Oryza
sativa)
–
–
cry1Ab (Bacillus
thuringiensis, subsp
berliner 1715)
bar (Streptomyces
hygroscopicus)
3’ NADP-me1
(Flaveria
bidentis)
3’ nos (A.
tumefaciens)
GHB119 35S (Cauliﬂower
Mosaic virus)
Pcsvmv XYZ (Cassava
Vein Mosaic Virus)
5’ cab22L (Petunia
hybrida)
–
TpssuAt (ats1A
gene of A.
thaliana)
–
cry2Ae (Bacillus
thuringiensis subsp.
dakota 1715)
bar (Streptomyces
hygroscopicus strain
ATCC21705)
3’ 35S
(Cauliﬂower
Mosaic virus)
3’ nos (A.
tumefaciens)
–: when no element was speciﬁcally introduced to optimise expression.
Table 3: Characteristics and intended effects of the events stacked in cotton GHB614 9 T304-
40 9 GHB119
Event Protein Donor organism and function Intended effects in GM plant
GHB614 2mEPSPS Based on a gene from Zea mays, 5-
enolpyruvyl-shikimate-3-phosphate
synthase (EPSPS) is an enzyme involved in
the shikimic acid pathway for aromatic
amino acid biosynthesis in plants and
microorganisms (Lebrun et al., 2003)
The amino acid sequence of the maize
EPSPS enzyme was modiﬁed by two
substitutions to render it tolerant to
glyphosate. Expression of 2mEPSPS
confers tolerance to glyphosate-
containing herbicides
7 Dossier: Part II –Section 1.2.1.2.
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3.4.1.2. Integrity of the events in the three-event stack8,9
The genetic stability of the inserted DNA over multiple generations in single cotton events GHB614,
T304-40 and GHB119 was demonstrated previously (see Table 1). Integrity of these events in cotton
GHB614 9 T304-40 9 GHB119 was demonstrated by Southern analyses. In addition, the sequence of
the events (inserts and their ﬂanking regions) was determined in the three-event stack cotton
GHB614 9 T304-40 9 GHB119 and compared to the sequences originally reported for the three single
events. The sequences of the events in the three-event stack and in the single events were found to
be identical, thus conﬁrming that the integrity of these events was maintained in the three-event stack
cotton.
3.4.1.3. Information on the expression of the inserts10
2mEPSPS, PAT, Cry1Ab and Cry2Ae protein levels were analysed by enzyme-linked immunosorbent
assay (ELISA), in material harvested in a ﬁeld trial across three locations in the USA in 2013. Samples
analysed included leaf (4–6 leaf, square initiation, 2 weeks after ﬂowering), root (4–6 leaf), pollen
(ﬂowering), squares (2 weeks after ﬂowering), bolls (2 weeks after ﬂowering), whole plant (2 weeks
after ﬂowering) and fuzzy seed (maturity) both those treated and not treated with glyphosate- and/or
glufosinate ammonium-containing herbicides. Since seeds are the main raw commodities used for food
and feed purposes, protein levels in seeds from GHB614 9 T304-40 9 GHB119 (the highest mean
values, regardless the treatment) are summarised in Table 4.
Event Protein Donor organism and function Intended effects in GM plant
T304-40 Cry1Ab
PAT
Based on genes from Bacillus thuringiensis,
subsp berliner 1715, Cry1Ab confers
resistance to insect pests of the
leptidopteran family; its insecticidal activity
is attributed to the expression of crystal
protein (cry) genes (Schnepf et al., 1998)
Based on the bar gene from Streptomyces
hygroscopicus, Phosphinothricin-acetyl-
transferase (PAT) enzyme confers
resistance to the antibiotic bialaphos (Eckes
et al., 1989)
Cotton T304-40 expresses a chimeric,
truncated cry1Ab gene. Cry1Ab is a
chimeric protein toxic to certain
lepidopteran larvae feeding on cotton
Cotton T304-40 expresses the PAT
protein, which acetylates L-glufosinate-
ammonium and thereby confers tolerance
to glufosinate ammonium-based
herbicides
GHB119 Cry2Ae
PAT
Based on genes from Bacillus thuringiensis
subsp. dakota 1715, Cry1Ae confers
resistance to insect pests of the
leptidopteran family; its insecticidal activity
is attributed to the expression of crystal
protein (cry) genes (Schnepf et al., 1998)
Based on the bar gene from Streptomyces
hygroscopicus strain ATCC21705,
Phosphinothricin-acetyl-transferase (PAT)
enzyme confers resistance to the antibiotic
bialaphos (Eckes et al., 1989)
Cotton GHB119 expresses a cry2Ae gene.
Cry2Ae is a chimeric protein toxic to
certain lepidopteran larvae feeding on
cotton
Cotton GHB119 expresses the PAT
protein, which acetylates L-glufosinate-
ammonium and thereby confers tolerance
to glufosinate ammonium-based
herbicides
8 Dossier: Part II–Section 1.2.2.2.a
9 Dossier: Part II–Section 1.2.2.4
10 Dossier: Part II–Section 1.2.3; additional information: 27/3/2017, 30/3/2017 and 28/7/2017.
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In order to assess changes in protein expression levels which may result from potential interactions
between the events, protein levels were determined for the three-event cotton stack and the
corresponding single events in different parts of the plant.
The levels of all the proteins newly expressed in the three-event cotton stack and the
corresponding singles were similar in all tissues, except for PAT protein levels expected to be different
because of the combination of events T304-40 and GHB119 both producing PAT protein in the
three-event stack cotton (Appendix A). Therefore, there is no indication of an interaction that may
affect the levels of the newly expressed proteins in this stack.
3.4.1.4. Conclusion of the molecular characterisation
The molecular data establish that the events stacked in cotton GHB614 9 T304-40 9 GHB119 have
retained their integrity. Protein expression analyses showed that the levels of the newly expressed
proteins are similar in the three-event stack cotton and in the single events. PAT shows the expected
higher level in the stack resulting from the combination of events T304-40 and GHB119. Therefore,
there is no indication of an interaction that may affect the integrity of the events and the levels of the
newly expressed proteins in this stack.
Based on the known biological function (Table 3) of the newly expressed proteins, the only
foreseen interactions at the biological level are between the two Cry proteins, which will be dealt with
in Sections 3.6 and 3.7.
3.5. Comparative analyses11
3.5.1. Choice of comparator and production of material for the comparative
analysis
Application EFSA-GMO-NL-2014-122 presents data on agronomic and phenotypic characteristics as
well as on cottonseed composition of the three-event stack cotton GHB614 9 T304–40 9 GHB119
derived from ﬁeld trials performed in the US in 2012 (Table 5).
Table 4: Highest mean values and corresponding standard deviation and ranges of protein levels (lg/g
dry weight) in seed (n = 11 or n = 12) from cotton GHB614 9 T304-40 9 GHB119 either
treated with glyphosate- and glufosinate ammonium-containing herbicides or not treated
Tissue/Developmental stage 2mEPSPS PAT Cry1Ab Cry2Ae
Seed/maturity 160.35(a)  26.61(b)
(132.13–227.84)(c)
219.46  30.14
(179.53–265.46)
6.37  1.80
(4.07–9.34)
29.15  6.14
(19.10–39.14)
(T) (T) (NT) (NT)
(a): Mean.
(b): Standard deviation.
(c): Range.
(T): treated with intended herbicides; (NT): not treated with intended herbicides.
Table 5: Overview of comparative assessment studies with cotton GHB614 9 T304–40 9 GHB119
Study focus Study details Comparator
Non-GM reference
varieties(a)
Agronomic and phenotypic
characteristics and
compositional analysis
Field trials, 2012, US, eight locations Coker 312 Six(b)
Agronomic and phenotypic
analysis
Seed germination study – controlled
conditions, two temperature regimes
Coker 312 –
(a): Three non-GM reference varieties were grown at each location.
(b): The six non-GM commercial reference varieties that were included in the ﬁeld trials are: FM958, FM989, ST457, DP491,
ST468 and Acala Maxxa.
11 Dossier: Part II–Section 1.3
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The ﬁeld trial study was conducted at eight sites representative of major cotton-growing areas of the
US,12 with diverse agronomic practices and environmental conditions. At each site, the following materials
were grown in a randomised complete block design with four replicates: cotton GHB614 9 T304-
40 9 GHB119, a comparator (Coker 312) and three non-GM reference varieties, all treated (sprayed) with
plant protection products according to local requirements, and cotton GHB614 9 T304–40 9 GHB119
treated with the intended herbicides (glyphosate- and glufosinate ammonium-containing herbicides) in
addition to the other plant protection products. A total of six12 non-GM cotton reference varieties were
included in the ﬁeld trial study. The non-GM cotton line (Coker 312) used as comparator had a genetic
background similar to that of the three-event stack cotton as documented by the pedigree13 and was
considered to be a suitable comparator by the GMO Panel.
The statistical analysis of the agronomic, phenotypic and compositional data followed the
recommendations of the GMO Panel (EFSA GMO Panel, 2011a) and complied with Regulation (EU)
503/2013. This included, for each of the two treatments of cotton GHB614 9 T304–40 9 GHB119, the
application of a difference test (between the GM cotton and the comparator) and an equivalence test
(between the GM cotton and the set of non-GM reference varieties). The results of the equivalence
test are categorised into four possible outcomes (I–IV, ranging from equivalence to non-equivalence).14
3.5.2. Agronomic and phenotypic analysis
3.5.2.1. Agronomic and phenotypic characteristics tested under ﬁeld conditions15
Twenty-seven agronomic and phenotypic endpoints were evaluated in the 2012 ﬁeld trial study.16
The endpoints were analysed applying the test of difference and equivalence with the exception of
disease reaction, boll type and stalk lodged plants. The latter endpoints were analysed with the
Cochran–Mantel–Haenszel test (CMH test).
• Statistically signiﬁcant differences between the three-event stack cotton not treated with the
intended herbicides and the comparator were identiﬁed for early stand count, total cottonseed
yield, lint yield, percentage of lint, ﬁbre micronaire, ﬁbre length uniformity, ﬁbre strength, ﬁbre
yellowness and total number of nodes.
• Statistically signiﬁcant differences between the three-event stack cotton treated with the
intended herbicides and its comparator were identiﬁed for early stand count, days to ﬁrst open
bolls, percentage of lint, ﬁbre micronaire, ﬁbre length, ﬁbre reﬂectance, ﬁbre yellowness, total
number of nodes, total number of bolls per plant and ﬁrst fruiting branch.
Except for the percentage of lint17 that fell under category IV (GM cotton not treated with the
intended herbicides) and category III (GM treated with the intended herbicide), all these endpoints fell
under equivalence categories I and II. For the endpoints analysed with the CMH test, no signiﬁcant
differences were identiﬁed between the three-event stack cotton and its comparator, and the observed
means fell within the range of the tested non-GM reference varieties.
3.5.2.2. Agronomic and phenotypic characteristics tested under controlled conditions
The applicant tested the germination potential of GHB614 9 T304–40 9 GHB119 cottonseed
compared to its comparator Coker 312 under warm and cold temperature regimes.18 The endpoints
12 The sites for the ﬁeld trials were in Chula (Georgia); West Memphis (Arkansas); Wall (Texas); Seven Springs (North Carolina);
Tallassee (Alabama); Uvalde (Texas); Edmonson (Texas); and Levelland (Texas).
13 Spontaneous information: 13/12/2016 and additional information: 14/2/2017.
14 In detail, the four outcomes are: category I (indicating full equivalence to the non-GM reference varieties); category II
(equivalence is more likely than non-equivalence); category III (non-equivalence is more likely than equivalence); and
category IV (indicating non-equivalence).
15 Dossier: Part II – Section A3.4.
16 Early season observations: days to emergence, early stand count, disease reaction. Mid-season observations:
number of days to ﬁrst ﬂower, number of days to ﬁrst open bolls, disease reaction, percentage of open bolls, boll type, stalk
lodged plants, total seed cotton yield, lint yield. Boll Properties: number of seeds per boll, boll size, seed index, percentage of
lint. Fibre properties: length, length uniformity, strength, micronaire, elongation, reﬂectance, yellowness. Plant Mapping: plant
height, total number of nodes, ﬁrst fruiting branch, total number of bolls per plant, height to node ratio.
17 Mean values for % lint were as follows: comparator exposed to conventional herbicides: 38.16; GHB614 9 T304-40 9 GHB119
(exposed to the intended herbicides): 36.55; GHB614 9 T304-40 9 GHB119 (exposed to conventional herbicides): 36.18.
Equivalence limits for % lint from non-GM reference varieties exposed to conventional herbicides: (37.15, 42.44).
18 Warm germination test conditions: seeds were incubated at 30°C5°C for 8 days without light. Cold germination test
conditions: seeds were incubated at 105°C for 7 days and then transferred 30°C5°C for 8 days without light. For both test
conditions, the germination conditions were evaluated at 4 and 8 days after the start of incubation at 30°C5°C.
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analysed were the numbers of normal germinated seeds, abnormal germinated seeds and ungerminated
seeds. For all endpoints, no statistically signiﬁcant differences between GHB614 9 T304–40 9 GHB119
cottonseed and its comparator at the two tested temperatures were observed.
3.5.3. Compositional analysis
Together with the ﬁeld trial study conducted in the US in 2012 described in Table 5, two additional
studies on composition analysis were made available by the applicant.19 The GMO Panel did not
consider these two additional studies for the risk assessment since they did not comply with EFSA
requirements as described in Regulation (EU) 503/2013.
Regarding the ﬁeld trial study in the US in 2012 (Table 5), fuzzy cottonseed was analysed for 73
different constituents, including the key constituents recommended by the OECD (OECD, 2009). For 20
cottonseed components,20 more than 50% of the observations were below the limit of quantiﬁcation
and were not analysed.
The statistical analysis was applied to the remaining 53 constituents.21 The test of equivalence
could not be applied to moisture in GHB614 9 T304-40 9 GHB119 cottonseed (not treated and
treated) because of the lack of variation among the non-GM reference varieties. A summary of the
outcome of the test of difference and the test of equivalence is presented in Table 6.
• For GHB614 9 T304-40 9 GHB119 cottonseed (not treated), all the 33 endpoints for which
signiﬁcant differences were found as compared to the comparator fell under equivalence
category I or II in the equivalence test, except for total fat, dihydrosterculic acid and
a-linolenic acid that fell under category III/IV.
• For GHB614 9 T304-40 9 GHB119 cottonseed (treated), all the 35 endpoints for which
signiﬁcant differences were found as compared to the comparator fell under equivalence
category I or II in the equivalence test, except for total fat, dihydrosterculic acid and
a-linolenic acid, that fell under category III/IV.
• For both treated and not treated GHB614 9 T304-40 9 GHB119 cottonseed, palmitic acid fell
under equivalence category III, although no statistically signiﬁcant differences were identiﬁed
with the comparator.
Table 6: Outcome of the comparative compositional analysis in GHB614 9 T304-40 9 GHB119
cottonseed. The table shows the number of endpoints in each category
Test of difference(a)
Not Treated(c) Treated(c)
Not different
Signiﬁcantly
different
Not different
Signiﬁcantly
different
Test of
equivalence(b)
Category I/II 18 30(d) 16 32(d)
Category III/IV 1(e) 3(f) 1(e) 3(f)
Not categorised 1(g) – 1(g) –
Total endpoints 53 53
(a): Comparison between GHB614 9 T304-40 9 GHB119 cottonseed and its comparator.
(b): Four different outcomes: category I (indicating full equivalence to the non-GM reference varieties); category II (equivalence
is more likely than non-equivalence); category III (non-equivalence is more likely than equivalence); and category IV
(indicating non-equivalence). Not categorised means that the test of equivalence was not applied because of the lack of
variation among the non-GM reference varieties.
19 Additional studies M-398053-01-1 (carried out in Spain in 2009) and M-372931-01-1 (carried out in US in 2009).
20 Sodium, b and d tocopherol and the fatty acids caprylic (C8:0), capric (C10:0), lauric (C12:0), myristoleic (C14:1),
pentadecanoic (C15:0), pentadecenoic (C15:1), c-Linolenic (C18:3), octadecatetraenoic (C18:4), Eicosenoic (C20:1),
eicosadienoic (C20:2), eicosatrienoic (C20:3), arachidonic (C20:4), eicosapentaenoic (C20:5), erucic (22:1), n3-
docosapentaenoic (C22:5), n6-docosapentaenoic (C22:5) and docosahexaenoic (C22:6).
21 Moisture, ash, fat, protein, magnesium, carbohydrate, ADF, NDF, zinc, potassium, calcium, phosphorus, manganese, iron,
copper, alanine, arginine, aspartic acid, cysteine, glutamic acid, glycine, histidine, tryptophan, isoleucine, leucine, lysine,
methionine, phenylalanine, proline, serine, threonine, tyrosine, valine, a tocopherol, c tocopherol, total tocopherols, free
gossypol, total gossypol, myristic acid (C14:0), palmitic acid (C16:0), palmitoleic acid (C16:1), heptadecanoic acid (C17:0),
stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2), linolenic acid (C18:3), arachidic acid (C20:0), behenic acid
(C22:0), lignoceric acid (C24:0), malvalic acid, phytic acid, sterculic acid, dihydrosterculic acid.
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The GMO Panel assessed all signiﬁcant differences between GHB614 9 T304-40 9 GHB119
cottonseed and its comparator, taking into account potential impact on plant metabolism and the
natural variability observed for the set of non-GM reference varieties. Mean estimates for the endpoints
showing signiﬁcant differences between GHB614 9 T304-40 9 GHB119 cottonseed and its
comparator, falling under category III/IV are given in Table 7.
3.5.4. Conclusion of the comparative analysis
Given the magnitude of the observed differences, the nature of the endpoints and the outcome of
the equivalence test, the GMO Panel considers that none of the agronomic and phenotypic differences
between GM cotton GHB614 9 T304-40 9 GHB119 and the comparator needs further assessment for
its potential environmental impact except the percentage of lint, which is further discussed in
Section 3.7.1.
The GMO Panel assessed all the compositional changes identiﬁed in the three-event stack cotton
with respect to its comparator and the non-GM reference varieties. Based on the outcome of both the
difference and the equivalence test, the GMO Panel does not identify any need for further food/feed
safety assessment except for total fat, dihydrosterculic acid and a-linolenic acid, which are further
discussed in Sections 3.6.3 and 3.6.6.
3.6. Food and feed safety assessment
3.6.1. Effects of processing
Cotton GHB614 9 T304-40 9 GHB119 will undergo existing production processes used for
conventional cotton. No novel production process is envisaged. Based on the outcome of the
comparative assessment, processing cotton GHB614 9 T304-40 9 GHB119 into food and feed
(c): Treated/not treated with intended herbicide: glyphosate- and glufosinate ammonium-containing herbicides (see
Section 3.5.1).
(d): Endpoints with signiﬁcant differences between GHB614 9 T304-40 9 GHB119 cottonseed and its comparator falling in
equivalence category I-II. For both treated and not treated GM: protein, carbohydrates, NDF, calcium, c tocopherol, total
tocopherols, free gossypol, total gossypol, sterculic acid, alanine, arginine, cysteine, glutamic acid, glycine, histidine,
isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tyrosine, valine, palmitoleic acid (C16:1),
oleic acid (C18:1), linoleic acid (C18:2); for the not treated GM only: magnesium, aspartic acid; for the treated GM only:
ash, potassium, phosphorus, manganese. The EFSA GMO Panel noted that the free gossypol content in raw cottonseeds of
both cotton GHB614 9 T304-40 9 GHB119 and its comparator was higher in certain sites than the limits set in Directive
2002/32 EC (5,000 mg/kg as fed) on undesirable substances in feed materials.
(e): Palmitic acid (16:0) fell under equivalence category III, although no statistically signiﬁcant differences were identiﬁed with
respect to the comparator.
(f): Endpoints with signiﬁcant differences between GHB614 9 T304-40 9 GHB119 cottonseed and its comparator and falling in
equivalence category III-IV. Estimated means are reported for these endpoints in Table 7.
(g): Endpoints not categorised for equivalence and with no signiﬁcant differences between GHB614 9 T304-40 9 GHB119
cottonseed and its comparator: moisture.
Table 7: Quantitative results (estimated means and equivalence limits) for endpoints with signiﬁcant
differences between GHB614 9 T304-40 9 GHB119 cottonseed and its comparator, falling
under category III and category IV in the test of equivalence (see Table 6)
Endpoint
GHB614 3 T304-
40 3 GHB119 cottonseed Non-GM
comparator
Equivalence limits from
non-GM reference varieties
Not treated Treated(a) Mean Equivalence limits
Fat
(% DM)
16.4* 16.3* 17.6 18.34 (16.51, 20.39)
a-Linolenic acid
(% FA)
0.215* 0.210* 0.187 0.18 (0.156, 0.202)
Dihydrosterculic acid
(% FA)
0.137* 0.139* 0.157 0.21 (0.170, 0.251)
(a): Treated with herbicide/s glyphosate- and glufosinate ammonium-containing herbicides as described in Section 3.5.1. For
GHB614 9 T304-40 9 GHB119 cottonseed, signiﬁcantly different values are marked with an asterisk, while the outcomes of
the test of equivalence are differentiated by greyscale backgrounds: light grey (equivalence category III) and dark grey
(equivalence category IV). dm = dry matter; FA = total fatty acids.
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products is not expected to result in products being different from those of conventional non-GM
cotton varieties.
3.6.2. Inﬂuence of temperature and pH on newly expressed proteins
Effects of temperature and pH on 2mEPSPS, PAT, Cry1Ab and Cry2Ae proteins have been previously
evaluated by the GMO Panel (Table 1). Additional studies22 addressing heat stability of these newly
expressed proteins were provided by the applicant. The outcome of these studies is consistent with
previous analogous studies assessed by the GMO Panel.
3.6.3. Toxicology
Testing of newly expressed proteins23
Four proteins (2mEPSPS, PAT, Cry1Ab and Cry2Ae) are newly expressed in cotton GHB614 9 T304-
40 9 GHB119 (Section 3.4.1). The GMO Panel has previously assessed these proteins in the context of
the single cotton events (Table 1), and no safety concerns were identiﬁed for humans and animals.
The GMO Panel is not aware of any new information that would change these conclusions.
The potential for a functional interaction between the proteins newly expressed in cotton
GHB614 9 T304-40 9 GHB119 has been assessed with regard to human and animal health. The
2mEPSPS and PAT proteins are enzymes that catalyse distinct biochemical reactions and act on unrelated
substrates with high substrate speciﬁcity. The Cry1Ab and Cry2Ae proteins are delta endotoxins with
high-speciﬁc insecticidal properties acting through cellular receptors found in target insect species. It is
reported that the gastrointestinal tract of mammals, including humans, lacks receptors with high-speciﬁc
afﬁnity to Cry proteins (Hammond et al., 2013; Koch et al., 2015). On the basis of the known biological
functions of the individual newly expressed proteins (Table 3), there is currently no expectation for
possible interactions relevant for the food and feed safety of the three-event stack cotton.
In vitro protein degradation studies on 2mEPSPS, PAT, Cry1Ab and Cry2Ae proteins have been
previously evaluated by the EFSA GMO Panel (Table 1). Additional studies24 addressing in vitro protein
degradation of these newly expressed proteins were provided by the applicant. No indications of safety
concerns are identiﬁed by the GMO Panel. The outcome of these studies is consistent with previous
analogous studies assessed by the GMO Panel.
The applicant provided two acute studies in mice with the PAT protein, which were evaluated by
the GMO Panel.25 An Escherichia coli -derived PAT protein was administered by gavage in two separate
studies at the doses of ~ 1,800 mg/kg body weight (bw) to male and female C57BL/6J mice and
~ 1,880 mg/kg bw to female C57BL/6J mice. No adverse effects related to the PAT protein were
observed in these studies.
The GMO Panel concludes that there are no safety concerns for human and animal health related
to the newly expressed proteins 2mEPSPS, PAT, Cry1Ab and Cry2Ae in cotton GHB614 9 T304-
40 9 GHB119.
Testing of new constituents other than proteins24
No new constituents other than newly expressed proteins have been identiﬁed in cotton
GHB614 9 T304-40 9 GHB119. Therefore, no further food and feed safety assessment of components
other than the newly expressed proteins is required.
Information on altered levels of food and feed constituents25
Fat, a-linolenic acid and dihydrosterculic acid were signiﬁcantly different in cotton GHB614 9 T304-
40 9 GHB119 when compared to its comparator and showed lack of equivalence with the set of non-
GM reference varieties (see Section 3.5.3).
Changes observed in fat and in a-linolenic acid are considered not to pose a toxicological concern in
cotton GHB614 9 T304-40 9 GHB119 considering their biological characteristics and functions and the
magnitude of the observed changes.
22 Dossier: Part II–Section 7 and additional information: 13/12/2016.
23 Dossier: Part II – Section 1.4.1.
24 Dossier: Part II – Section 1.4.2.
25 Dossier: Part II – Section 1.4.3.
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Dihydrosterculic acid belongs to the category of cyclopropenoid fatty acids (CPFA) present in cotton
oil described as antinutrients (OECD, 2009). CPFA are considered to inhibit the desaturation of saturated
fatty acids and have been associated with detrimental effects in animals (OECD, 2009). Since the level of
dihydrosterculic acid was lower in cotton GHB614 9 T304-40 9 GHB119 as compared to its comparator,
the GMO Panel considers that there are no toxicological concerns related to this change.
The GMO Panel concludes that there are no toxicological concerns as regards the changes in fat,
a-linolenic acid and dihydrosterculic acid observed in cotton GHB614 9 T304-40 9 GHB119 as
compared to its comparator and the non-GM reference varieties.
Testing of the whole genetically modiﬁed food and feed26
No indication of potential adverse effects relevant for food/feed safety were identiﬁed for cotton
GHB614 9 T304-40 9 GHB119 regarding the stability of the inserts, the expression of the inserts and
the potential synergistic or antagonistic effects resulting from the combination of the transformation
events (see Sections 3.4.1, 3.5.3 and 3.6.3). Therefore, animal studies on food/feed derived from
cotton GHB614 9 T304-40 9 GHB119 are not necessary (EFSA GMO Panel, 2011a). In accordance to
Regulation (EU) No 503/2013, the applicant provided 90-day oral repeated-dose toxicity studies on
whole food and feed from cottons GHB614, T304-40 and GHB119. The GMO Panel previously
concluded that the 90-day studies on cotton GHB119 and T304-40 were not suitable for the
assessment, due to the low number of experimental units used (cage) (EFSA GMO Panel, 2013, 2016).
The 90-day study on cotton GHB614 had the same study design limitations. In the frame of the
present application, the applicant performed complementary statistical analyses allowing the use of
individual animals instead of cage as the experimental unit following the recommendations of EFSA
Scientiﬁc Committee (EFSA Scientiﬁc Committee, 2011).
90-day feeding study in rats – GHB119 cotton
Wistar Rj:WI (IOPS HAN) rats (10/sex per group) were allocated to four groups and to different cages
within each group (2 cages/sex per group, 5 animals/cage), using a computerised, stratiﬁed
randomisation based on individual body weights within each sex. Groups were fed diets containing
approximately 5% or 10%(w/w) cottonseed toasted meal from GHB119 cotton sprayed with
glufosinate27 (test diets); 10%(w/w) cottonseed toasted meal from the conventional counterpart (Coker
312, control diet). In addition; 10 rats/sex per group were given a diet containing 10%(w/w) cottonseed
toasted meal from a commercial non-transgenic cotton (FM958, reference diet). The study provided was
adapted from OECD TG 408 and complying with the principles of Good Laboratory Practice (GLP).
The GMO Panel previously concluded that this study was not suitable for the assessment, due to
inappropriate statistical analysis and low number of experimental units (cage) (EFSA GMO Panel,
2016). Following the recommendations of EFSA Scientiﬁc Committee (EFSA Scientiﬁc Committee,
2011), the applicant performed complementary statistical analyses allowing the use of individual
animals instead of cage as the experimental unit.28 The analysis showed that there was overall no
relevant cage effect, i.e. no relevant variation of the parameters between different cages. Based on
those results, the GMO Panel accepts the statistical analysis of data based on individual animals.
Balanced diets were prepared according to the speciﬁcations for SAFE standard rodent maintenance
diet. Comprehensive compositional analysis of the cottonseed meal from GHB119 cotton, from the
conventional counterpart and from the reference variety was performed.29 Test, control and reference
diets were analysed for key nutrients, ﬁbres, minerals, gross energy, cotton antinutrients, mycotoxins,
heavy metals and pesticides. Event-speciﬁc polymerase chain reaction (PCR) analysis on the test diets
conﬁrmed their molecular identity.
The diets were prepared and analysed in a non-GLP facility; however, standardised procedures and
quality measures were followed. Therefore, the GMO Panel considers that this is not a major deviation
impacting the study.
Stability of the test and control materials was not tested; however, in accordance to product
expiration standards declared by the diet manufacturer, the constituents of the diets are considered
stable for the duration of the treatment. There are currently no practical analytical methods available
26 Dossier: Part II – Section 1.4.4.
27 Glufosinate was applied once during the crop growth stage 1st ﬂowering, at a rate of 500 g a.i./ha. Additional information:
20/2/2018.
28 Study: M-513407-01-1 and additional information 19/2/2018 and 15/5/2018.
29 Dossier: Part II – Section 1.4.1.1.
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to determine homogeneity and concentration of cottonseed toasted meal in the formulated diets. Diet
preparation procedures guaranteed their homogeneity and the proper concentration of the test,
control or reference substances in them.
Feed and water were provided ad libitum. Animals were checked twice daily for mortality and at least
once daily for clinical signs. Detailed physical examinations were conducted on all animals pretreatment
and then weekly during the dosing period. Individual body weights were recorded pretreatment, the ﬁrst
day of dosing, weekly during the dosing period and on the day prior to the scheduled necropsy. Feed
consumption (per cage) was determined weekly during the study (twice weekly the ﬁrst 6 weeks).
Ophthalmoscopy and functional observation battery (FOB) and motor activity parameters were recorded
on all animals pretreatment and at the end of the study. Clinical pathology (i.e. haematology, clinical
chemistry and coagulation), urine analyses and necropsy examination with selected organs weighing
were conducted at the end of the treatment period on all animals. The animals were fasted overnight
prior to blood collection and while in metabolism cages for urine collection. Organs and tissues from 10%
test diet, control and reference diet as well as gross lesions from all groups were subjected to a detailed
histopathological examination. Upon completion of the histopathologic assessment of all tissues,
histopathology was reviewed by a peer review pathologist.
The main statistical analysis compared rats consuming each of the two test diets (5% and 10%) with
those consuming the control diet. The comparison was done using two analysis of variance (ANOVA)
models: combined-gender ANOVA30 and gender-speciﬁc ANOVA. Additional comparisons were performed
between the two test groups and the reference group (both combined-gender and gender-speciﬁc
ANOVA), and between the control group and the reference group (only gender-speciﬁc ANOVA).31
The few statistically signiﬁcant differences between the control and reference diet groups in the
examined parameters are considered by the GMO Panel to be within normal biological variability.
No mortalities were observed during the study. No test diet-related clinical signs and
ophthalmoscopic ﬁndings were seen.
Feed consumption was similar across groups.
A statistically signiﬁcant increase in mean body weight gain/day observed in females given 10%
test diet (on day 57 only) as compared to controls is not considered to be test diet-related.
A statistically signiﬁcantly lower hind limb grip strength was observed in the neuromuscular
observations in test diet-fed female rats (15% and 17% decrease in 5% and 10% test diet groups,
respectively, as compared to controls). This was the only change among the parameters examined in
the FOB and therefore, not considered to be test diet-related.
An increased mean exploratory locomotor activity (at one of six repeated measurements) in male
rats given the 5% test diet as compared to controls was considered as an incidental ﬁnding.
No statistically signiﬁcant haematological changes were noted in rats given the test diets as
compared to controls.
Statistically signiﬁcant increased prothrombin time was noted in females given the 10% test diet as
compared to controls (~ 9%). Due to the small magnitude of the change and since this was not
associated with changes in related endpoints (e.g. no difference in the platelet count across groups
given the test diets and the controls or in the spleen and bone marrow histopathology), the GMO
Panel considers that this change is not adverse.
No statistically signiﬁcant differences in clinical chemistry parameters were noted between rats
given the test diets and their controls, except for a decreased total bilirubin in males given the 10%
test diet (~ 29%). This ﬁnding was not associated with changes in related endpoints (e.g. other liver
clinical chemistry parameters and liver histopathology) and therefore, not considered as being adverse.
No statistically signiﬁcant differences in urinalysis parameters were observed in animals given the
test diets, as compared to controls.
Males given the 5% test diet showed statistically signiﬁcant increased thymus weight (~ 30% for
both absolute and relative to body weight and to brain weight) as compared to controls. Since this
ﬁnding was not dose-related and no test diet-related changes were seen for thymus weight and in
30 For the combined-gender analysis, following on a preliminary check for homogeneity of variance (Bartlett test), the applicant
performed either a parametric ANOVA or a non-parametric (aligned rank transform) ANOVA, followed by a test of sex-by-dose
interaction. If the interaction was not signiﬁcant, differences between groups were investigated using ANOVA and either a
parametric (Dunnet’s) or non-parametric (Dunn’s) test. If the interaction was signiﬁcant, the combined-gender analysis was
considered not appropriate and no further testing was done. The ANOVA models included sex and dose as main effects and
(only for interaction testing) a sex-by-dose interaction term.
31 Study: M-432216-01-1.
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macroscopic and microscopic examination of the thymus from rats given the 10% test diet, the GMO
Panel does not consider this ﬁnding to be toxicologically relevant.
Rats given the 5% test diet showed a statistically signiﬁcant increase (in the combined analysis) in
thyroid weight (~ 19% for both absolute and relative to body weight and to brain weight) as
compared to controls. In the gender separated analysis, the thyroid weight (~ 24% relative to brain
weight only) in the 5% test diet-fed males was signiﬁcantly increased as compared to controls. Since
this ﬁnding was not dose-related and no test diet-related changes were seen for thyroid weight and in
macroscopic and microscopic examination of the thyroid from rats given the 10% test diet, the GMO
Panel does not consider this ﬁnding to be toxicologically relevant.
A statistically signiﬁcant decreased spleen weight (~ 8%, for both absolute and relative to body
weight) was noted in rats given the 10% test diet (in the combined analysis) as compared to controls;
since the magnitude of the change was small and not associated with macroscopic or microscopic
ﬁndings in the spleen, this ﬁnding is not considered to be adverse.
No test diet-related gross lesions or microscopic ﬁndings were noted in the examined organs or
tissues. Sporadic histopathological ﬁndings are considered compatible with the spontaneous
background pathology of rats of this strain and age.
The GMO Panel concludes that no cotton GHB119-related adverse effects were observed in this study
after a 90-day administration to rats of a diet formulated with 5% and 10% cottonseed toasted meal.
90-day feeding study in rats – GHB614 cotton
Wistar Rj:WI (IOPS HAN) rats (10/sex per group) were allocated to four groups and to different
cages within each group (2 cages/sex per group, 5 animals/cage), using a computerised, stratiﬁed
randomisation based on individual body weights within a sex. Groups were fed diets containing
approximately 5% or 10%(w/w) cottonseed toasted meal from GHB614 cotton sprayed with the
glyphosate32 (test diets); 10%(w/w) cottonseed toasted meal from the comparator Fibermax 958
(control diet). In addition; 10 rats/sex per group were given a diet containing 10%(w/w) cottonseed
toasted meal from a non-transgenic cotton (Acala GTO Maxxa, reference diet). The study provided was
adapted from OECD TG 408 and complying with the principles of GLP.
Following the recommendations of EFSA Scientiﬁc Committee (EFSA Scientiﬁc Committee, 2011),
the applicant performed complementary statistical analyses33 allowing the use of individual animals
instead of cage as the experimental unit. The analysis showed that there was overall no relevant cage
effect, i.e. no relevant variation of the parameters between different cages. Based on those results,
the GMO Panel accepts the statistical analysis of data based on individual animals.
Balanced diets were prepared according to the speciﬁcations for SAFE standard rodent maintenance
diet. Comprehensive compositional analysis of the cottonseed meal from GHB614 cotton, from the
comparator and from the reference variety was performed.34 Test, control and reference diets were
analysed for key nutrients, ﬁbres, minerals, gross energy, cotton antinutrients, mycotoxins, heavy
metals and pesticides. Event-speciﬁc PCR analysis on the test diets conﬁrmed their molecular identity.
The diets were prepared and analysed in a non-GLP facility; however, standardised procedures and
quality measures were followed. Therefore, the GMO Panel considers this not a major deviation
impacting the study.
Stability of the test and control materials was not tested; however, in accordance to product
expiration standards declared by the diet manufacturer, the constituents of the diets are considered
stable for duration of the treatment. There are currently no practical analytical methods available to
determine homogeneity and concentration of cottonseed toasted meal in the formulated diets. Diet
preparation procedures guaranteed their homogeneity and the proper concentration of the test,
control or reference substances in them.
Feed and water were provided ad libitum. Animals were checked twice daily for mortality and at
least once daily for clinical signs. Detailed physical examinations were conducted on all animals
pretreatment and then weekly during the dosing period. Individual body weights were recorded
pretreatment, the ﬁrst day of dosing, weekly during the dosing period and on the day prior to the
scheduled necropsy. Feed consumption (per cage) was determined weekly during the study (twice
weekly the ﬁrst 6 weeks). Ophthalmoscopy and FOB and motor activity parameters were recorded on
32 Glyphosate was applied once during the crop growth stage 4 leaves, at a rate of 1260 g a.i./ha. Dossier: Part II – 1.4.1.1 and
additional information: 20/2/2018.
33 Study: M-513410-01-1 and additional information 19/2/2018 and 15/5/2018.
34 Technical dossier Part II – 1.4.1.1.
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all animals pretreatment and at the end of the study. Clinical pathology (i.e. haematology, clinical
chemistry and coagulation), urinalyses and necropsy examination with selected organs weighing were
conducted at the end of the treatment period on all animals. The animals were fasted overnight prior
to blood collection and while in metabolism cages for urine collection. Organs and tissues from 10%
test diet, control and reference diet as well as gross lesions from all groups were subjected to a
detailed histopathological examination. Upon completion of the histopathologic assessment of all
tissues, histopathology was reviewed by a peer review pathologist.
The main statistical analysis compared rats consuming each of the two test diets (5% and 10%)
with those consuming the control diet. Additional comparisons were performed between the two test
groups and the reference group and between the control group and the reference group.35 All
comparisons were done with an ANOVA applied separately to males and females.
The few statistically signiﬁcant differences between the control and reference diet groups in the
examined parameters are considered by the GMO Panel to be within normal biological variability.
No treatment-related mortalities occurred. One control male was killed for humane reasons; this
was attributed to an accidental trauma. No test diet-related clinical signs and ophthalmoscopic ﬁndings
were seen.
Feed consumption was similar across groups.
No statistically signiﬁcant differences in body weight parameters were noted in rats given the test
diets as compared to controls.
No differences in FOB and exploratory locomotor activity parameters were seen between rats given
the test diets and controls.
No test diet-related haematological and coagulation changes were seen.
Females given 10% test diet showed statistically signiﬁcant increased mean alkaline phosphatase
activity (~ 29%) and increased mean inorganic phosphorus concentration (~ 11%) as compared to
controls. These ﬁndings were not associated with changes in related endpoints (e.g. other clinical
chemistry parameters and histopathological ﬁndings indicating liver or kidney toxicity) and therefore
not considered to be adverse.
No test diet-related changes in the urinalysis were seen.
A statistically signiﬁcant increased heart weight (~ 11%, relative to brain weight only) was noted in
females given the 10% test diet as compared to controls; this ﬁnding is not considered to be adverse
since the magnitude of the change was small, it was not accompanied by statistical signiﬁcant
difference in both the heart absolute and relative to body weight, and it was not associated with
macroscopic or microscopic ﬁndings in the heart.
No test diet-related gross lesions or microscopic ﬁndings were noted in the examined organs or
tissues. Sporadic histopathological ﬁndings are considered compatible with the spontaneous
background pathology of rats of this strain and age.
The GMO Panel concludes that no cotton GHB614-related adverse effects were observed in this study
after a 90-day administration to rats of a diet formulated with 5% and 10% cottonseed toasted meal.
90-day feeding study in rats – T304-40 cotton
Wistar Rj:WI (IOPS HAN) rats (10/sex per group) were allocated to four groups, and to different
cages within each group (2 cages/sex per group, 5 animals/cage), using a computerised, stratiﬁed
randomisation based on individual body weights within a sex. Groups were fed diets containing
approximately 5% or 10%(w/w) cottonseed toasted meal from T304-40 cotton (test diets); 10%(w/w)
cottonseed toasted meal from the conventional counterpart (Coker 315, control diet). In addition; 10
rats/sex per group were given a diet containing 10%(w/w) cottonseed toasted meal from a commercial
non-transgenic cotton (FM958, reference diet). The study provided was adapted from OECD TG 408 and
complying with the principles of GLP.
The GMO Panel previously concluded that this study was not suitable for the assessment, due to
inappropriate statistical analysis and low number of experimental units (cage) (EFSA GMO Panel,
2013). Following the recommendations of EFSA Scientiﬁc Committee (EFSA Scientiﬁc Committee,
2011), the applicant performed complementary statistical analyses allowing the use of individual
animals instead of cage as the experimental unit.36 The analysis showed that there was overall no
relevant cage effect, i.e. no relevant variation of the parameters between different cages. Based on
those results, the GMO Panel accepts the statistical analysis of data based on individual animals.
35 Study: M-430107-01-1.
36 Study: M-513420-01-1 and additional information 19/2/2018 and 15/5/2018.
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Balanced diets were prepared according to the speciﬁcations for SAFE standard rodent maintenance
diet. Comprehensive compositional analysis of the cottonseed meal from T304-40 cotton, from the
conventional counterpart and from the reference variety was performed.37 Test, control and reference
diets were analysed for key nutrients, ﬁbres, minerals, gross energy, cotton antinutrients, mycotoxins,
heavy metals and pesticides. Event-speciﬁc PCR analysis on the test diets conﬁrmed their molecular
identity.
The diets were prepared and analysed in a non-GLP facility; however, standardised procedures and
quality measures were followed. Therefore, the GMO Panel considers this not a major deviation
impacting the study.
Stability of the test and control materials was not tested; however, in accordance to product
expiration standards declared by the diet manufacturer, the constituents of the diets are considered
stable for the duration of the treatment. There are currently no practical analytical methods available
to determine homogeneity, and concentration of cottonseed toasted meal in the formulated diets. Diet
preparation procedures guaranteed their homogeneity and the proper concentration of the test,
control or reference substances in them.
Feed and water were provided ad libitum. Animals were checked twice daily for mortality and at
least once daily for clinical signs. Detailed physical examinations were conducted on all animals
pretreatment and then weekly during the dosing period. Individual body weights were recorded
pretreatment, the ﬁrst day of dosing, weekly during the dosing period and on the day prior to the
scheduled necropsy. Feed consumption (per cage) was determined weekly during the study (twice
weekly the ﬁrst 6 weeks). Ophthalmoscopy and FOB and motor activity parameters were recorded on
all animals pretreatment and at the end of the study. Clinical pathology (i.e. haematology, clinical
chemistry and coagulation), urinalyses and necropsy examination with selected organs weighing were
conducted at the end of the treatment period on all animals. The animals were fasted overnight prior
to blood collection and while in metabolism cages for urine collection. Organs and tissues from 10%
test diet, control and reference diet as well as gross lesions from all groups were subjected to a
detailed histopathological examination. Upon completion of the histopathologic assessment of all
tissues, histopathology was reviewed by a peer review pathologist.
The main statistical analysis compared rats consuming each of the two test diets (5% and 10%)
with those consuming the control diet. An additional comparison was performed between the control
group and the reference group. All comparisons were done with an ANOVA applied separately to males
and females.
The few statistically signiﬁcant differences between the control and reference diet groups in the
examined parameters are considered by the GMO Panel to be within normal biological variability.
No mortalities were observed during the study. No treatment-related clinical signs and
ophthalmoscopic ﬁndings were observed.
Feed consumption was similar across groups.
No statistically signiﬁcant differences in body weight parameters were noted in rats given the test
diets as compared to controls.
A statistically signiﬁcantly higher mean forelimb grip strength in females given the 10% test diet
and increased mean landing foot splay value in females given the 5% test diet were noted as
compared to controls. These were the only changes among the parameters examined in the FOB and
therefore, not considered to be test diet-related. No test diet-related changes in exploratory locomotor
activity parameters were seen.
No test diet-related haematological, coagulation, clinical chemistry and urinalysis ﬁndings were seen.
An increased spleen weight (~ 19%, relative to body weight) was seen in females given the 5%
test diet as compared to controls. Since this ﬁnding was not dose-related and no test diet-related
changes were noted for spleen weight and in macroscopic and microscopic examination of the spleen
from rats given the 10% test diet, the GMO Panel does not consider this ﬁnding to be toxicologically
relevant.
No test diet-related gross lesions or microscopic ﬁndings were noted in the examined organs or
tissues. Sporadic histopathological ﬁndings are considered compatible with the spontaneous
background pathology of rats of this strain and age.
The GMO Panel concludes that no cotton T304-40-related adverse effects were observed in this
study after a 90-day administration to rats of a diet formulated with 5% and 10% cottonseed toasted
meal.
37 Dossier: Part II – 1.4.1.1
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3.6.4. Allergenicity
For the allergenicity assessment, a weight-of-evidence approach was followed, taking into account
all the information obtained on the newly expressed proteins, as no single piece of information or
experimental method yields sufﬁcient evidence to predict allergenicity (Codex Alimentarius, 2009; EFSA
GMO Panel, 2011a; Regulation (EU) 503/2013). In addition, when known functional aspects of the
newly expressed protein or structural similarity to known adjuvants may indicate an adjuvant activity,
the possible role of these proteins as adjuvants is considered. When newly expressed proteins with a
potential adjuvant activity are expressed together, possible interactions increasing adjuvanticity and
impacting the allergenicity of the GM crop are assessed.
Assessment of allergenicity of newly expressed proteins38
For allergenicity, the GMO Panel has previously evaluated the safety of the proteins 2mEPSPS, PAT,
Cry1Ab and Cry2Ae individually, and no concerns on allergenicity were identiﬁed in the context of the
applications assessed (Table 1). No new information on allergenicity of these proteins that might
change the previous conclusions of the GMO Panel in the context of the GM events assessed has
become available. Based on the current knowledge, and as none of the newly expressed proteins
showed allergenicity, no reasons for concerns regarding the simultaneous presence of these newly
expressed proteins in this three-event stack cotton affecting their allergenicity were identiﬁed.
For adjuvanticity, proteins derived from Bacillus thuringiensis (Bt proteins) have been suggested to
possess adjuvant activity based on animal studies on Cry1Ac when applied at relatively high doses
(e.g. Vazquez et al., 1999). The GMO Panel has previously evaluated the safety of the Cry1Ab and
Cry2Ae proteins and no concerns on adjuvanticity in the context of the applications assessed were
identiﬁed (Table 1). The levels of Bt proteins in this three-event stack cotton are similar to those in the
respective single cotton events (Appendix A). From the limited experimental evidence available, the
GMO Panel does not ﬁnd indications that the presence of the Bt proteins at the levels expressed in this
three-event stack cotton might act as adjuvants with the potential to enhance a speciﬁc
immunoglobulin E (IgE) response and to favour the development of an allergic reaction.
Assessment of allergenicity of the whole GM plant39
The GMO Panel regularly reviews the available publications on food allergy to cottonseed-derived
products. However, to date, cotton has not been considered to be a common allergenic food40 (OECD,
2009). Therefore, the GMO Panel does not request experimental data to analyse the allergen
repertoire of GM cotton.
Conclusion
In the context of this application and considering the data from the molecular characterisation, the
compositional analysis and the assessment of the newly expressed proteins (see Sections 3.4.1, 3.5.3
and 3.6.3), the GMO Panel identiﬁes no indications of a potentially increased allergenicity of food and
feed derived from this three-event stack cotton with respect to that derived from the comparator.
3.6.5. Dietary exposure assessment to endogenous and new constituents
In line with Regulation (EU) No 503/2013, the applicant provided dietary exposure to 2mEPSPS,
PAT, Cry1Ab and Cry2Ae proteins present in cotton GHB614 9 T304-40 9 GHB119.
3.6.5.1. Human dietary exposure
The applicant estimated the dietary exposure to 2mEPSPS, PAT, Cry1Ab and Cry2Ae proteins as
negligible based on the fact that all protein compounds from cottonseed are removed or destroyed
during the production of reﬁned cottonseed oil of food grade quality, and that no consumption data of
cottonseed and derived products is available in the European Comprehensive Food Consumption
Database.
38 Dossier: Part II – 1.5.1 and 1.5.3, 7 and additional information: 13/12/2016.
39 Dossier: Part II – 1.5.2.
40 Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food
information to consumers, amending Regulations (EC) No 1924/2006 and (EC) No 1925/2006 of the European Parliament and
of the Council, and repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/
EC, Directive 2000/13/EC of the European Parliament and of the Council, Commission Directives 2002/67/EC and 2008/5/EC
and Commission Regulation (EC) No 608/2004.
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The GMO Panel identiﬁed different food products for human consumption such as ﬂour and oil that can
be derived from cottonseed, with the latter being the most important. Availability of consumption data on
this type of products was searched in the EFSA Comprehensive European Food Consumption Database;
this database contains information on food consumption data at individual level from the most recent
national dietary surveys in different EU Member States (EFSA, 2011).41 The GMO Panel conﬁrms that no
data on consumption of cottonseed oil as such or cottonseed ﬂour are available in the EFSA consumption
database. However, cottonseed oil is consumed as this oil is used as an ingredient in the production of a
wide variety of food products such as dressings, mayonnaise, ﬁne bakery wares, chocolate spreads and
chips.42 Considering that reﬁned bleached deodorised cottonseed oil is free from proteins, no dietary
exposure to 2mEPSPS, PAT, Cry1Ab and Cry2Ae proteins is expected from the consumption of oil derived
from cotton GHB614 9 T304-40 9 GHB119. On the other hand, dietary exposure to these proteins
cannot be excluded through the consumption of cottonseed ﬂour. However, the presence of these
products is currently minor in the European market, and therefore, the GMO Panel concludes that, under
the current situation, the dietary exposure to 2mEPSPS, PAT, Cry1Ab and Cry2Ae proteins is negligible.
3.6.5.2. Animal dietary exposure
Daily dietary exposure (DDE) to the 2mEPSPS, PAT, Cry1Ab, and Cry2Ae proteins newly expressed
in cotton GHB614 9 T304-40 9 GHB119 was provided by the applicant across different livestock
animal species (poultry, swine, cattle and sheep)43 based on EU estimates issued by OECD (OECD,
2013) for animal body weight, daily feed intake and the inclusion rates (percentage) of undelinted
fuzzy cottonseed (i.e. dairy cows only) and cottonseed meal in animal diets. A conservative scenario
with 100% replacement of the conventional cotton (e.g. undelinted fuzzy cottonseed and cottonseed
meal) was considered. The mean levels of 2mEPSPS, PAT, Cry1Ab and Cry2Ae proteins in undelinted
fuzzy cottonseeds were used by the applicant as occurrence data for both cottonseed and meal.44
Estimated DDEs to the 2mEPSPS, based on mean levels in GM cotton undelinted seed was
617.34 lg/kg bw per day in dairy cows. Estimated DDEs to the 2mEPSPS protein based on mean
levels in GM cotton meal ranged from 192.42 lg/kg bw per day in beef to 1144.89 lg/kg bw per day
in turkey.45
Estimated DDEs to the PAT, based on mean levels in GM cotton undelinted seed was 844.92 lg/kg
bw per day in dairy cows. Estimated DDEs to the PAT protein based on mean levels in GM cotton meal
ranged from 263.35 lg/kg bw per day in beef to 1566.94 lg/kg bw per day in turkey.46
Estimated DDEs to the Cry1Ab, based on mean levels in GM cotton undelinted seed was 24.52 lg/kg
bw per day in dairy cows. Estimated DDEs to the Cry1Ab protein based on mean levels in GM cotton meal
ranged from 7.64 lg/kg bw per day in beef to 45.48 lg/kg bw per day in turkey.47
Estimated DDEs to the Cry2Ae, based on mean levels in GM cotton undelinted seed was 112.22 lg/kg
bw per day in dairy cows. Estimated DDEs to the Cry2Ae protein based on mean levels in GM cotton meal
ranged from 34.98 lg/kg bw per day in beef to 208.13 lg/kg bw per day in turkey.48
The GMO Panel considers that after extraction of the oil, crude protein in cottonseed meals/cakes
increases by a factor of 1.6–2, based on the protein content of cotton meal relative to cottonseed
(OECD, 2009), assuming that no protein is lost during the processing. Therefore, the above-reported
values for the newly expressed proteins present in meal should be adjusted accordingly.
3.6.6. Nutritional assessment of GM food/feed
The intended trait of cottonseed GHB614 9 T304-40 9 GHB119 is insecticide resistance and
herbicide tolerant, with no intention to alter the nutritional parameters. However, total fat, a-linolenic
41 https://www.efsa.europa.eu/en/applications/gmo/tools
42 The Mintel’s Global New Products Database (GNPD) is an online database which monitors product
introduction in consumer packaged goods markets worldwide (http://www.mintel.com/global-new-products-database).
43 Poultry (broiler, layer and turkey); swine (breading and ﬁnishing); cattle (beef and dairy cows); sheep (ram/ewe and lamb).
44 Following the submission of additional information upon EFSA request, the GMO Panel referred to mean level data
(Appendix A).
45 Estimated DDEs: 192.42, 307.87, 801.75, 681.48, 370.40, 240.52, 566.03, 548.39, 1144.89 µg/kg per bw, respectively, in beef
and dairy cows, ram/ewe and lamb, breeding and ﬁnishing swine, broiler chicken, layer hen and turkey.
46 Estimated DDEs: 263.35, 421.36, 1097.3, 932.7, 506.95, 329.19, 774.69, 750.55, 1566.94, µg/kg per bw, respectively, in beef
and dairy cows, ram/ewe and lamb, breeding and ﬁnishing swine, broiler chicken, layer hen and turkey.
47 Estimated DDEs: 7.64, 12.23, 31.85, 27.07, 14.71, 9.55, 22.48, 21.78, 45.48 µg/kg per bw, respectively, in beef and dairy
cows, ram/ewe and lamb, breeding and ﬁnishing swine, broiler chicken, layer hen and turkey.
48 Estimated DDEs: 34.98, 55.96, 145.75, 123.88, 67.33, 43.72, 102.89, 99.69, 208.13 µg/kg per bw, respectively, in beef and
dairy cows, ram/ewe and lamb, breeding and ﬁnishing swine, broiler chicken, layer hen and turkey.
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acid and dihydrosterculic acid in both treated and not treated GHB614 9 T304-40 9 GHB116
cottonseeds were signiﬁcantly different from its comparator and showed a lack of equivalence with the
set of non-GM reference varieties (Section 3.5). The biological role of these compounds, their levels in
cottonseed and the magnitude and direction of the observed changes were considered during the
nutritional assessment.
3.6.6.1. Human nutrition49
Oil is the most important cottonseed-derived product used for human consumption. In Europe, the
consumption of cottonseed oil as such seems to be minor as reﬂected by the lack of consumption data
reported in the EFSA Comprehensive Food Consumption Database. However, cottonseed oil is used as
an ingredient in the production of a wide variety of food products such as dressings, mayonnaise, ﬁne
bakery wares, chocolate spreads and chips. Cottonseed oil is rich in linoleic acid (about 50% of total
FA), poor in a-linolenic acid (~ 0.2% of total FA) and contains approximately 25% saturated fatty
acids, among which palmitic acid is the most prominent (about 20% of total FA) (Dowd et al., 2010).
Because it has no ﬂavour, it is suitable for cooking.
The 12–15% increase in content of a-linolenic acid (% of total FA) in GHB614 9 T304-40 9 GHB119
cottonseed as compared to the comparator will not substantially change the daily intake of a-linolenic
acid when GHB614 9 T304-40 9 GHB116 cottonseed oil replaces conventional cottonseed oil.
The dihydrosterculic acid content in GHB614 9 T304-40 9 GHB119 cottonseed was lower than that
in the comparator (11–13% of total FA) and the six non-GM reference varieties (19–45%).
Dihydrosterculic acid (cyclopropaneoctanoic acid, 8-(2-octylcyclopropyl)octanoic acid) is one of a group
of cyclopropane fatty acids (CPA) that together with cyclopropene fatty acids (CPE) occur infrequently
in most plants. Dihydrosterculic acid makes up 0.2–0.4% of total fatty acids in cottonseed (Xiao-Hong
et al., 2011). CPAs are derived from unsaturated fatty acids, e.g. oleic acid, by cyclopropanation. No
information is available about effects in humans. CPAs will be destroyed during reﬁning and
hydrogenation of vegetable oils; therefore, changes in levels of dihydrosterculic acid in cottonseed
should not raise health concerns.
3.6.6.2. Animal nutrition50
Cotton can be fed to animals, mainly as cottonseed cake/meal or full fat seeds, especially in
ruminants. In complete feeds, its use is limited to 5–10% because of the content of antinutritional
factors.
A decrease in total fat content does not affect animal nutrition since complete diets are balanced to
energy content.
Cyclopropane fatty acids (CPA) are inhibitors of several fatty acid desaturases in animals, and this
implies an increase of saturated fatty acids in animal fat (Phelps et al., 1965). Page et al. (1997) observed
that feeding whole cottonseeds containing CPA, affect lipogenesis, but does not inﬂuence the activity of
stearoyl coenzyme desaturase in liver and adipose tissue. Therefore, a reduction in dihydrosterculic acid
content in GHB614 9 T304-40 9 GHB119 cottonseed is not expected to affect animal health.
Linolenic acids are commonly present in most commercially edible plant oils fed to animals;
a-linolenic acid cannot be synthetised in mammals and is commonly supplied to animals in diets as an
essential fatty acid (Mc Donalds, 2011). The GMO Panel considers the increase in content of a-linolenic
acid in GHB614 9 T304-40 9 GHB119 of no safety concern, since animal complete feeds are regularly
balanced for linolenic acid.
3.6.7. Conclusion of the food and feed safety assessment
The proteins 2mEPSPS, PAT, Cry1Ab and Cry2Ae newly expressed in cotton GHB614 9 T304-
40 9 GHB119 do not raise safety concerns for human and animal health in light of the scope of this
application. No interactions between these newly expressed proteins relevant for food and feed safety
were identiﬁed. Similarly, the GMO Panel does not identify indications of safety concerns regarding
allergenicity or adjuvanticity related to the presence of the newly expressed proteins in cotton
GHB614 9 T304-40 9 GHB119, or regarding the overall allergenicity of the three-event stack cotton.
Based on the outcome of the comparative assessment and the nutritional assessment, the GMO
Panel concludes that the nutritional impact of cotton GHB614 9 T304-40 9 GHB119-derived food and
49 Dossier: Part II – Section 1.6.1.
50 Dossier: Part II – Section 1.6.2
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feed is expected to be the same as those derived from the comparator and non-GM reference varieties.
The GMO Panel concludes that cotton GHB614 9 T304-40 9 GHB119, as described in this application, is
nutritionally equivalent to and as safe as the comparator and the non-GM reference varieties tested.
3.7. Environmental risk assessment51
Considering the scope of application EFSA-GMO-NL-2014-122, which excludes cultivation, the ERA
of cotton GHB614 9 T304-40 9 GHB119 mainly takes into account: (1) the exposure of
microorganisms to recombinant DNA in the gastrointestinal tract of animals fed GM material and of
microorganisms present in environments exposed to faecal material of these animals (manure and
faeces); and (2) the accidental release into the environment of viable GHB614 9 T304-40 9 GHB119
cottonseeds during transportation and processing (EFSA GMO Panel, 2010).
3.7.1. Persistence and invasiveness of the GM plant52
In southern Europe, Gossypium herbaceum, G. barbadense and G. hirsutum have been grown
since the 19th century and led to transient or locally naturalised cotton plants in the same area (Davis,
1967; Tutin et al., 1992; Sarno et al., 1993; Celesti-Grapow et al., 2010). However, survival of
cottonseeds outside cultivation areas in Europe is limited due to the absence of a seed dormancy
phase. Even if seeds from spillage germinate, the resulting cotton plants are unlikely to survive due to
factors such as cold climatic conditions, the susceptibility to diseases and their low competitiveness
(Eastick and Hearnden, 2006). For example, after the end of cotton cultivation in Italy in 1950s, no
feral cotton was reported in southern Italy, except in some restricted areas (Sarno et al., 1993; Celesti-
Grapow et al., 2010). Also, in other cotton-growing regions, such as Australia, surveys showed that
feral GM cotton established infrequently along transportation routes and mostly as transient
populations (Addison et al., 2007). Field observations indicate that cottonseed may survive and
overwinter in some EU regions, resulting in volunteers in subsequent crops (e.g. Charles et al., 2013).
However, cotton volunteers have been shown to rarely yield as well as newly planted seeds due to
seedling diseases and early emergence in cool conditions. Thus, the establishment and survival of feral
and volunteer cotton plants in the EU is currently limited and transient.
It is unlikely that the intended traits of cotton GHB614 9 T304–40 9 GHB119 will provide a
selective advantage to cotton plants, except when they are exposed to glyphosate- and/or glufosinate
ammonium-containing herbicides or infested by insect pests that are susceptible to the Cry1Ab and/or
Cry2Ae proteins.
The GMO Panel considers that the ﬁtness advantage provided by the intended traits, and the
observed difference in percentage of lint (see Section 3.5.2.1) will not allow the GM plant to overcome
other biological and abiotic factors (described above) limiting plant’s persistence and invasiveness.
Therefore, the presence of the intended traits and other observed differences will not affect the
persistence and invasiveness of the GM plant.
In conclusion, the GMO Panel considers it very unlikely that cotton GHB614 9 T304–40 9 GHB119
will differ from conventional cotton varieties in its ability to survive until subsequent seasons, or to
establish occasional feral plants under European environmental conditions in case of accidental release
into the environment of viable GHB614 9 T304-40 9 GHB119 cottonseeds.
3.7.2. Potential for gene transfer53
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic
material, either through HGT of DNA or through vertical gene ﬂow via cross-pollination from feral
plants originating from spilled seeds.
Plant-to-microorganism gene transfer
The probability and potential adverse effects of HGT of the recombinant DNA have been assessed
previously for the single events (see Table 1). No concern as a result of an unlikely, but theoretically
possible, HGT of the recombinant genes to bacteria in the gut of domesticated animal and humans fed
GM material or other receiving environments was identiﬁed. The applicant submitted an updated
bioinformatic analysis for each of the single events in order to assess possibility for HGT by HR.
51 Dossier: Part II – Section 5.
52 Dossier: Part II – Section 5.3.1.
53 Dossier: Part II – Section 5.3.1 and 5.3.2.
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Bioinformatic analysis54 for event GHB614 revealed no sequence identity with bacterial DNA; thus,
there is no indication of facilitated gene transfer of recombinant DNA of event GHB614 to bacteria.
The bioinformatic analysis54 for events T304-40 and GHB119 conﬁrmed previous assessments, in
which for both events, two elements with sufﬁcient sequence identity and length with bacterial DNA
were observed. These were the bar-coding sequence from Streptomyces hygroscopicus and the 3’ nos
terminator from the Agrobacterium tumefaciens Ti plasmid. Considering that these sequences occur in
two relatively unrelated bacterial genomes, there is no indication for a potential double HR.
Synergistic effects of the recombinant genes, for instance due to combinations of recombinogenic
sequences, which would cause an increase in the likelihood for HGT or a selective advantage were not
identiﬁed.
Therefore, the GMO Panel concludes that the unlikely, but theoretically possible, horizontal transfer
of recombinant genes from this three-event stack cotton to bacteria does not raise any environmental
safety concern.
Plant-to-plant gene transfer
The potential for occasional feral cotton GHB614 9 T304-40 9 GHB119 plants originating from
seed import spills to transfer recombinant DNA to sexually compatible plants and the environmental
consequences of this transfer were considered.
For plant-to-plant gene transfer to occur, imported GM cottonseeds need to germinate and develop
into plants in areas containing sympatric wild relatives and/or cultivated cotton with synchronous
ﬂowering and environmental conditions favouring cross-pollination.
Cotton is an annual predominantly self-pollinating crop, although cross-pollination can occur at low
frequencies in the presence of insect pollinators (such as wild bees, honeybees, bumblebees) (OECD,
2008). For cotton, no wild relatives have been reported in Europe; therefore, any vertical gene transfer
is limited to G. hirsutum, G. barbadense and G. herbaceum cotton plants. However, gene transfer to
G. herbaceum is considered unlikely due to the difference in ploidy level.
The potential of spilled cottonseeds to establish, grow and produce pollen is extremely low and
transient (see Section 3.7.1). The likelihood/frequency of cross-pollination between occasional feral GM
cotton plants resulting from seed spillage and weedy or cultivated Gossypium plants is therefore also
considered extremely low. Even if cross-pollination would occur, the GMO Panel is of the opinion that
the likelihood of environmental effects as a consequence of the spread of genes from occasional feral
GM cotton plants in Europe will not differ from that of conventional cotton varieties for the reasons
given in Section 3.7.1.
3.7.3. Interactions of the GM plant with target organisms55
Taking the scope of application EFSA-GMO-NL-2014-122 (no cultivation) and thus the absence of
target organisms into account, potential interactions of occasional feral cotton GHB614 9 T304–
40 9 GHB119 plants arising from seed import spills with the target organisms are not considered a
relevant issue by the GMO Panel.
3.7.4. Interactions of the GM plant with non-target organisms56
Given that environmental exposure of non-target organisms to spilled GM seeds or occasional feral
GM cotton plants arising from spilled GHB614 9 T304-40 9 GHB119 cottonseeds is limited and because
most proteins are degraded before entering the environment through faecal material of animals fed GM
cottonseed, potential interactions of the cotton GHB614 9 T304–40 9 GHB119 with non-target
organisms are not considered by the GMO Panel to raise any environmental safety concern. Interactions
that may occur between the Cry proteins (as mentioned in Section 3.4.1.1) will not alter this conclusion.
3.7.5. Interactions with abiotic environment and biogeochemical cycles57
Given that environmental exposure to spilled seeds or occasional feral cotton GHB614 9 T304–
40 9 GHB119 plants arising from seed import spills is limited and because most proteins are degraded
before entering the environment through faecal material of animals fed GM cotton, potential
54 Additional information: 2/2/2018.
55 Dossier: Part II – Section 5.3.3.
56 Dossier: Part II – Section 5.3.4.
57 Dossier: Part II – Section 5.3.6.
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interactions with the abiotic environment and biogeochemical cycles are not considered by the GMO
Panel to raise any environmental safety concern.
3.7.6. Conclusion of the environmental risk assessment
The GMO Panel concludes that it is unlikely that cotton GHB614 9 T304-40 9 GHB119 would differ
from conventional cotton varieties in its ability to persist under European environmental conditions.
Considering the scope of application EFSA-GMO-NL-2014-122, interactions of occasional feral cotton
GHB614 9 T304-40 9 GHB119 plants with the biotic and abiotic environment are not considered to be
relevant issues. The analysis of HGT from the three-event stack cotton to bacteria does not indicate a
safety concern. Therefore, considering the combined traits and their interactions, the outcome of the
comparative analysis, the routes and levels of exposure, the GMO Panel concludes that cotton
GHB614 9 T304-40 9 GHB119 would not raise safety concerns in the event of accidental release of
viable GM cottonseeds into the environment.
3.8. Post-market monitoring
3.8.1. Post-market monitoring of GM food/feed
The GMO Panel concludes that cotton GHB614 9 T304-40 9 GHB119, as described in this application,
is nutritionally equivalent to and as safe as the comparator and the non-GM reference varieties tested, and
no post-market monitoring (EFSA GMO Panel, 2011a) of food/feed is considered necessary.
3.8.2. Post-market environmental monitoring58
The objectives of a PMEM plan, according to Annex VII of Directive 2001/18/EC, are: (1) to conﬁrm
that any assumption regarding the occurrence and impact of potential adverse effects of the GMO, or
its use, in the ERA are correct; and (2) identify the occurrence of adverse effects of the GMO, or its
use, on human health or the environment that were not anticipated in the ERA.
Monitoring is related to risk management, and thus, a ﬁnal adoption of the PMEM plan falls outside
the mandate of EFSA. However, the GMO Panel gives its opinion on the scientiﬁc rationale of the PMEM
plan provided by the applicant (EFSA GMO Panel, 2011b).
As the ERA did not identify potential adverse environmental effects from cotton GHB614 9 T304-
40 9 GHB119, no case-speciﬁc monitoring is required.
The PMEM plan proposed by the applicant for cotton GHB614 9 T304-40 9 GHB119 includes: (1) the
description of a monitoring approach involving operators (federations involved in import and processing),
reporting to the applicant, via a centralised system, any observed adverse effect(s) of GMOs on human
health and the environment; (2) a coordinating system established by EuropaBio for the collection of
information recorded by the various operators; and (3) the review of relevant scientiﬁc publications
retrieved from literature searches (Lecoq et al., 2007; Windels et al., 2008). The applicant proposes to
submit a PMEM report on an annual basis and a ﬁnal report at the end of the authorisation period.
The GMO Panel considers that the scope of the PMEM plan provided by the applicant is consistent
with the intended uses of cotton GHB614 9 T304-40 9 GHB119. The GMO Panel agrees with the
reporting intervals proposed by the applicant in its PMEM plan.
3.8.3. Conclusion on post-market monitoring
The scope of the PMEM plan provided by the applicant and the reporting intervals are in line with
the intended uses of cotton GHB614 9 T304-40 9 GHB119.
3.9. Overall conclusions
The GMO Panel was asked to carry out a scientiﬁc assessment of cotton GHB614 9 T304-
40 9 GHB119 for import, processing and food and feed uses in accordance with Regulation (EC)
No 1829/2003.
No new data on the single cotton events GHB614, T304-40 and GHB119 that would lead to a
modiﬁcation of the original conclusions on their safety were identiﬁed.
58 Dossier: Part II – Section 6.
Assessment of GM cotton GHB614 3 T304-40 3 GHB119
www.efsa.europa.eu/efsajournal 26 EFSA Journal 2018;16(7):5349
UN
DE
R 
RE
VI
EW
The molecular data establish that the events stacked in cotton GHB614 9 T304-40 9 GHB119 have
retained their integrity. Protein expression analysis shows that the levels of the newly expressed
proteins are similar in the three-event stack cotton and in the single events. PAT shows the expected
higher level in the stack resulting from the combination of the single cotton events T304-40 and
GHB119. Therefore, there is no indication of an interaction that may affect the integrity of the events
and the levels of the newly expressed proteins in this stack.
Given the magnitude of the differences observed in the comparative assessment, the nature of the
endpoints and the outcome of the equivalence test, the GMO Panel considers that none of the
agronomic and phenotypic differences between cotton GHB614 9 T304-40 9 GHB119 and the
comparator needs further assessment for its potential environmental impact except the percentage of
lint. This difference was further assessed and found not to affect the ability of cotton GHB614 9 T304-
40 9 GHB119 to survive until subsequent seasons or to establish occasional feral plants under
European environmental conditions. The GMO Panel does not identify the need for further food/feed
safety assessment on the composition characteristics except for total fat, dihydrosterculic acid and
a-linolenic acid. These differences were assessed and do not raise concerns with regard either food
and feed safety or nutritional relevance.
The proteins 2mEPSPS, PAT, Cry1Ab and Cry2Ae newly expressed in the three-event stack cotton
do not raise concerns for human and animal health and no interactions between these proteins
relevant for food and feed safety were identiﬁed. Similarly, the GMO Panel does not identify indications
regarding the overall allergenicity of the three-event stack cotton. The nutritional impact of cotton
GHB614 9 T304-40 9 GHB119-derived food and feed is expected to be the same as those derived
from the comparator and non-GM reference varieties.
The GMO Panel concludes that cotton GHB614 9 T304-40 9 GHB119, as described in this
application, is nutritionally equivalent to and as safe as the comparator and the non-GM reference
varieties tested, and no post-market monitoring of food/feed is considered necessary.
The GMO Panel concludes that there is a very low likelihood of environmental effects resulting from
the accidental release of viable seeds from cotton GHB614 9 T304-40 9 GHB119 into the environment.
Based on the relevant publications identiﬁed through the literature searches, the GMO Panel does
not identify any safety issues pertaining to the intended uses of cotton GHB614 9 T304-
40 9 GHB119. In the context of PMEM, the applicant should improve the future literature searches
according to the GMO Panel recommendations.
The PMEM plan and reporting intervals are in line with the intended uses of cotton
GHB614 9 T304-40 9 GHB119.
In conclusion, the GMO Panel considers that cotton GHB614 9 T304-40 9 GHB119, as described in
this application is as safe as its comparator and the tested non-GM cotton reference varieties with
respect to potential effects on human and animal health and the environment.
Documentation requested and provided to EFSA
• Letter from the Netherlands to EFSA received on 8 October 2014 for placing on the market of
genetically modiﬁed cotton GHB614 9 T304-40 9 GHB119 in accordance with articles 6 and
18 of Regulation (EC) No 1829/2003 by Bayer CropScience N.V. (EFSA-GMO-NL-2014-122).
• Acknowledgement letter dated 15 October 2014 from EFSA to the Netherlands.
• Letter from EFSA to applicant dated 4 December 2014 requesting additional information under
completeness check.
• Letter from applicant to EFSA received on 23 December 2014 extending the timeline to provide
additional information under completeness check.
• Letter from applicant to EFSA received on 23 February 2015 extending the timeline to provide
additional information under completeness check.
• Letter from applicant to EFSA received on 16 March 2015 extending the timeline to provide
additional information under completeness check.
• Letter from applicant to EFSA received on 23 March 2015 providing additional information
under completeness check.
• Letter from applicant to EFSA received on 9 April 2015 providing additional information under
completeness check.
• Letter from EFSA to applicant dated 30 April 2015 delivering the’Statement of Validity’ for
application EFSA-GMO-NL-2014-122.
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• Letter from EFSA to applicant dated 30 April 2015 stopping the clock due to the pending risk
assessment of single event cotton GHB119.
• Letter from EFSA to applicant dated 23 September 2016 restarting the clock due to ﬁnalisation
of risk assessment of single event cotton GHB119.
• Letter from EFSA to applicant dated 27 September 2016 requesting additional information and
stopping the clock.
• Letter from applicant to EFSA received on 13 December 2016 providing additional and
spontaneous information.
• Email from EFSA to applicant, dated 15 December 2016, re-starting the clock from 13
December 2016.
• Letter from EFSA to applicant dated 16 December 2016 requesting additional information and
stopping the clock.
• Letter from applicant to EFSA received on 14 February 2017 providing additional information.
• Email from EFSA to applicant, dated 14 February 2017, re-starting the clock.
• Letter from EFSA to applicant dated 23 February 2017 requesting additional information and
stopping the clock.
• Letter from applicant to EFSA received on 27 March 2017 providing additional information.
• Email from applicant to EFSA dated 30 March 2017 providing additional information.
• Email from EFSA to applicant, dated 30 March 2017, re-starting the clock.
• Letter from EFSA to applicant dated 12 April 2017 requesting additional information and
stopping the clock.
• Letter from EFSA to applicant dated 11 May 2017 requesting additional information and
maintaining the clock stopped.
• Letter from applicant to EFSA dated 12 May 2017 extending the timeline to provide additional
information.
• Letter from applicant to EFSA dated 9 June 2017 extending the timeline to provide additional
information.
• Letter from applicant to EFSA received on 28 July 2017 providing additional information.
• Email from EFSA to applicant, dated 31 July 2017, re-starting the clock from 28 July 2017.
• Letter from EFSA to applicant dated 1 August 2017 requesting additional information and
stopping the clock.
• Letter from EFSA to applicant dated 1 September 2017 requesting additional information and
maintaining the clock stopped.
• Letter from applicant to EFSA received on 15 September 2017 providing additional information.
• Email from EFSA to applicant, dated 18 September 2017, re-starting the clock from 15
September 2017.
• Letter from EFSA to applicant dated 7 December 2017 requesting additional information and
stopping the clock.
• Letter from applicant to EFSA received on 2 February 2018 providing additional information.
• Email from EFSA to applicant, dated 6 February 2018, re-starting the clock from 2 February
2018.
• Letter from EFSA to applicant dated 15 February 2018 requesting additional information and
stopping the clock.
• Letter from applicant to EFSA received on 20 February 2018 providing additional information.
• Email from EFSA to applicant, dated 21 February 2018, re-starting the clock from 20 February
2018.
• Letter from EFSA to applicant dated 28 March 2018 requesting additional information and
stopping the clock.
• Letter from applicant to EFSA received on 15 May 2018 providing additional information.
• Email from EFSA to applicant, dated 25 May 2018, re-starting the clock from 15 May 2018.
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Abbreviations
ANOVA analysis of variance
bw body weight
CPA cyclopropane fatty acids
CPE cyclopropene fatty acids
CPFA cyclopropenoid fatty acids
DDE Daily dietary exposure
ERA environmental risk assessment
ELISA enzyme-linked immunosorbent assay
FW fresh weight
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GLP Good Laboratory Practice
GM genetically modiﬁed
GMO Genetically modiﬁed organisms
HGT horizontal gene transfer
HR homologous recombination
IgE immunoglobulin E
ORFs Open Reading Frames
PAT phosphinothricin acetyltransferase
PCR polymerase chain reaction
PMEM post-market environmental monitoring plan
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Appendix A – Protein expression data
Means, standard deviation and ranges of protein levels (lg/g dry weight) from cotton
GHB614 9 T304-40 9 GHB119 (not treated), GHB614 (not treated), T304-40 (not treated) and
GHB119 (not treated) from ﬁeld trials performed in USA in 2013(a)
GHB614 3 T304-
40 3 GHB119
GHB614 T304-40 GHB119
PAT
Leaf (4–6 leaf) 551.30(b)  82.75(c)
(452.46–678.41)(d)
366.50  55.85
(292.28–455.13)
232.65  34.16
(178.30–293.36)
Leaf (square
initiation)
1366.02  481.35
(852.22–2164.34)
663.13  56.75
(553.32–746.27)
380.83  73.21
(294.73–512.23)
Leaf (2 weeks after
ﬁrst ﬂower)
770.37  183.41
(478.33–1083.54)
372.36  101.55
(220.05–552.15)
263.23  66.97
(174.27–399.16)
Root (4–6 leaf) 247.88  64.45
(160.15–361.73)
146.11  17.82
(115.87–167.46)
88.32  19.56
(34.90–105.17)
Pollen(e) (ﬂowering) 1.12  0.68
(0.50–2.30)
0.75  1.00
(0.03–3.31)
1.53  1.00
(0.29–3.06)
Squares (2 weeks
after
ﬁrst ﬂower)
1036.73  169.99
(803.85–1356.51)
536.98  195.59
(172.65–852.53)
323.46  34.84
(277.09–396.89)
Bolls (2 weeks after
ﬁrst ﬂower)
364.71  34.77
(313.85–420.69)
220.55  18.50
(196.41–251.86)
161.64  32.09
(131.84–246.23)
Whole plant
(2 weeks after
ﬁrst ﬂower)
489.07  80.88
(345.18–650.41)
322.14  115.35
(147.96–586.87)
165.98  14.14
(142.94–190.56)
Fuzzy seed
(maturity)
216.17  23.28
(175.51–248.65)
110.95  12.80
(85.41–130.41)
96.10  12.37
(74.80–117.54)
Cry1Ab
GHB614 3 T304-
40 3 GHB119
GHB614 T304-40 GHB119
Leaf (4–6 leaf) 16.74  6.77
(7.42–24.52)
15.15  6.58
(6.90–23.01)
Leaf (square
initiation)
27.41  12.92
(9.80–47.12)
20.03  8.90
(10.81–37.33)
Leaf (2 weeks after
ﬁrst ﬂower)
10.06  4.16
(2.31–15.46)
7.87  4.05
(1.93–13.92)
Root (4–6 leaf) 12.13  2.43
(8.03–16.39)
11.36  2.13
(8.98–16.17)
Pollen (ﬂowering) 0.20  0.11
(0.09–0.41)
0.35  0.23
0.12–0.82
Squares (2 weeks
after
ﬁrst ﬂower)
13.13  3.48
(9.82–19.02)
9.93  3.94
(4.87–16.78)
Bolls (2 weeks after
ﬁrst ﬂower)
10.81  2.57
(7.25–14.36)
9.38  1.82
(6.37–12.87)
Whole plant
(2 weeks after
ﬁrst ﬂower)
9.71  1.76
(7.05–11.92)
10.07  4.63
(5.98–22.19)
Fuzzy seed
(maturity)
6.37  1.80
(4.07–9.34)
6.56  1.25
(5.24–9.05)
Assessment of GM cotton GHB614 3 T304-40 3 GHB119
www.efsa.europa.eu/efsajournal 31 EFSA Journal 2018;16(7):5349
UN
DE
R 
RE
VI
EW
2mEPSPS
GHB614 3 T304-
40 3 GHB119
GHB614 T304-40 GHB119
Leaf (4–6 leaf) 410.37  63.16
(297.54–497.53)
405.31  50.37
(317.74–480.82)
Leaf (square
initiation)
1912.52  676.00
(876.48–2572.18)
1540.20  767.54
(495.63–2790.01)
Leaf (2 weeks after
ﬁrst ﬂower)
494.21  128.44
(303.34–749.60)
382.68  48.55
(287.74–475.37)
Root (4–6 leaf) 86.27  18.46
(54.05–109.59)
85.62  29.03
(22.19–123.87)
Pollen (ﬂowering) 8.24  3.19
(5.32–14.90)
8.95  6.69
(2.43–23.14)
Squares (2 weeks
after
ﬁrst ﬂower)
390.51  78.33
(267.43–499.86)
393.71  101.61
(251.09–538.67)
Bolls (2 weeks after
ﬁrst ﬂower)
143.35  21.32
(110.39–177.56)
158.84  23.38
(126.42–195.79)
Whole plant
(2 weeks after
ﬁrst ﬂower)
216.86  45.19
(155.57–311.10)
253.92  161.81
(171.84–754.31)
Fuzzy seed
(maturity)
154.57  20.89
(128.93–192.99)
159.36  13.06
(131.33–180.65)
Cry2Ae
GHB614 3 T304-
40 3 GHB119
GHB614 T304-40 GHB119
Leaf (4–6 leaf) 172.41  54.07
(102.09–263.04)
190.74  51.99
(95.49–268.24)
Leaf (square
initiation)
226.52  44.18
(165.69–305.99)
218.94  55.07
(157.80–324.63)
Leaf (2 weeks after
ﬁrst ﬂower)
138.84  27.59
(96.10–202.71)
119.66  37.03
(78.62–207.88)
Root (4–6 leaf) 10.81  5.91
(3.64–21.95)
12.19  2.90
(4.62–16.44)
Pollen (ﬂowering) 0.21  0.14
(0.04–0.58)
0.28  0.41
(0.06–1.56)
Squares (2 weeks
after
ﬁrst ﬂower)
42.75  13.09
(30.96–63.72)
42.16  14.95
(26.80–69.75)
Bolls (2 weeks after
ﬁrst ﬂower)
19.54  4.10
(13.58–24.75)
23.99  6.52
(14.91–38.02)
Whole plant
(2 weeks after
ﬁrst ﬂower)
111.81  31.51
(79.15–173.47)
135.11  46.13
(78.92–235.72)
Fuzzy seed
(maturity)
29.15  6.14
(19.10–39.14)
26.79  7.53
(15.00–35.10)
(a): Number of samples is n = 12 except for: PAT in leaf at square initiation and fuzzy seed (n = 11 for GHB614 9 T304-
40 9 GHB119); 2mEPSPS in leaf at square initiation and fuzzy seed (n = 11 for GHB614 9 T304-40 9 GHB119) and
squares (n = 11 for GHB614); Cry1Ab in fuzzy seed (n = 11 for GHB614 9 T304-40 9 GHB119); Cry2Ae in leaf/square
initiation and fuzzy seed (n = 11 for GHB614 9 T304-40 9 GHB119).
(b): Mean.
(c): Standard deviation.
(d): Range.
(e): Reported values for pollen are derived from fresh weight (FW) tissue.
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